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Summary 
Mycobacterium bovis (M. bovis) forms part of the Mycobacterium tuberculosis complex 
(MTC), a group of genetically related bacteria that causes tuberculosis in humans and animals. 
African buffaloes (Syncerus caffer) are maintenance hosts of M. bovis, the causative organism 
of bovine tuberculosis (bTB). Since this species acts as a bTB reservoir for a wide range of 
domestic and wildlife species, the detection of M. bovis-infected animals is essential to control 
spread of the disease. However, diagnostic assays used for bTB management and control 
programmes, such as the single intradermal comparative tuberculin test (SICTT) and 
commercially available interferon-gamma release assays (IGRAs), are still believed to be sub-
optimal for the diagnosis of bTB in bovids. A potential approach to improving detection of M. 
bovis infection could be the use of novel diagnostic antigens or the identification of alternative 
or ancillary biomarkers to interferon-gamma (IFN-γ). The studies presented in this dissertation 
aim to identify, develop and evaluate novel approaches for improving the detection of M. bovis 
infection in African buffaloes. 
The first objective was to evaluate the performance of two new commercially available IGRAs, 
the Bovigam® PC-EC assay and the Bovigam® PC-HP assay, for the first time in buffaloes and 
compare their performance to that of two versions of an adapted human IGRA, the modified 
QuantiFERON® TB-Gold (mQFT) assay. In addition, the effect of increased blood incubation 
time on sensitivity of the mQFT assay was assessed along with whether centrifugation was a 
necessary step prior to harvesting the plasma fraction. Furthermore, the relative sensitivities of 
Bovigam® assays, a modified Bovigam assay that contains an additional stimulation criteria 
with Mycobacterium fortuitum tuberculin and the SICTT were compared in identified M. bovis-
infected buffaloes. Combinations of these assays were evaluated to identify the optimal test 
algorithm (i.e., highest sensitivity) for detection of bTB in African buffaloes. Commercially 
available bovine ELISAs as well as a human IP-10 ELISA were used to identify selected 
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candidate biomarkers of M. bovis-specific immune activation and evaluate their diagnostic 
utility. Lastly, this study investigated what effect storing stimulated whole blood plasma under 
various conditions would have on the diagnostic performance of IP-10 assays in African 
buffaloes. 
Agreement between the Bovigam® PC-EC and the Bovigam® PC-HP assays was high (κ = 
0.86, 95% CI 0.75–0.97) and these detected the greatest number of test-positive animals 
suggesting that they were the most sensitive assays. Agreement between two versions of the 
mQFT assay was also high (κ=0.88, 95% CI 0.77-0.98); however, all buffaloes with discordant 
mQFT results (n=6), including 3 confirmed M. bovis-infected animals, were positive at 30 
hours incubation and negative at 20 hours. These results suggest that the mQFT assay is more 
sensitive using the longer incubation period (i.e., 30 hours). There were no significant 
differences in IFN-γ concentrations in plasma samples harvested from QFT tubes prior to and 
after centrifugation, a step which may facilitate plasma sampling over multiple incubation 
times to improve sensitivity. When the test performance of IFN-γ assays was compared in 
buffaloes, the Bovigam PPD assay had a relative sensitivity between 91-93% while the 
sensitivity of the modified PPD assay was between 90-91%. Diagnostic sensitivity was 
improved by combining one or more IGRA together with the SICTT (95-100%). Investigation 
of alternative biomarkers to IFN-γ found that IP-10 levels were significantly increased in 
antigen-stimulated blood samples from M. bovis-infected buffaloes (p < 0.0001).  In addition, 
IP-10 was produced in far greater abundance than IFN-γ, demonstrating its potential as a novel 
biomarker of bTB in buffaloes. Moreover, using IP-10, agreement between the mQFT assay 
and the Bovigam assays was increased while the excellent agreement between the Bovigam 
assays was retained. Since transport and storage of buffalo blood samples are important 
considerations for development of diagnostic tests for bTB, the effects of heat-inactivation and 
storage on protein saver cards (PSCs) on IP-10 performance were assessed. Incubation of 
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plasma at 65 °C for 20 min caused no statistically significant loss of IP-10 and this protein 
could be quantified in plasma stored on PSCs for 2 and 8 weeks. Moreover, for all storage 
conditions, IP-10 retained its excellent diagnostic characteristics. 
Diagnostic tests for bTB in wildlife are limited by the lack of species-specific immunological 
reagents. Logistical constraints make validation of tests, using novel biomarkers such as IP-10, 
more difficult. These limitations may preclude definitive conclusions about the diagnostic 
utility of IP-10 in buffaloes. Some of the factors that may have influenced our conclusions 
include: 1) limited sample size which could affect calculation of appropriate IP-10 test cut-off 
values; 2) use of antigen-specific whole-blood incubation assay protocols which had been 
optimized for measurement of IFN-γ rather than IP-10, and 3) lack of post-mortem samples to 
confirm M. bovis infection status in Bovigam-negative IP-10-positive buffaloes. 
In conclusion, both the Bovigam® PC-EC assay and the Bovigam® PC-HP assay were shown 
to be more sensitive than either the SICTT or mQFT assay in its current format. Plasma 
collected from the QFT tubes prior to centrifugation could be reliably utilized in this assay. 
Moreover, increasing the blood incubation time from 20h to 30h increased the mQFT assay’s 
sensitivity. In an additional study, both the Bovigam PPD assay and modified PPD assay 
displayed greatest sensitivity for the detection of M. bovis-infected buffaloes. The SICTT 
detected additional IGRA-negative animals and maximum sensitivity was attained when these 
assays were used in combination. In addition to IFN-γ, IP-10 appears to be a useful marker of 
immune activation in buffaloes when using a commercially available IP-10 bovine ELISA. IP-
10 shows promise as a diagnostic biomarker in M. bovis-infected buffaloes and measurement 
of IP-10 increased the sensitivity over conventional IGRAs. IP-10 could be measured in plasma 
stored on PSCs; however, the sensitivity of tests utilizing such samples was reduced with 
increased storage time. Plasma samples could be heated to 65 ºC for 20 min with no degradation 
of IP-10, demonstrating the thermal stability of this cytokine.  
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These findings are supported by previous cattle studies that advocate the parallel use of the 
SICTT and the Bovigam PPD assay. Moreover, these findings also highlight the potential 
application of IP-10 for the diagnosis of bTB in African buffaloes. Improved sensitivity of M. 
bovis-specific IGRAs is a significant advantage of using IP-10 as a preferred biomarker in this 
species. Other advantages of IP-10 are its thermal tolerance and stability on PSCs. These 
characteristics facilitate movement of diagnostic samples by permitting heat-inactivation of 
potential pathogens in plasma, and transport of samples by conventional delivery methods, 
respectively. 
  




Mycobacterium bovis (M. bovis) vorm deel van die Mycobacterium tuberculosis-kompleks 
(MTK), ǹ groep genetiesverwante bakterieë verantwoordelik vir tuberkulose in mense en diere. 
Die Kaapse buffel (Syncerus caffer) is ǹ reservoir (instandhoudingsgasheer) vir M. bovis, die 
bakterie verantwoordelik vir beestuberkulose (bTB). Omdat hierdie spesie as reservoir van 
infeksie vir ǹ verskeidenheid van plaasmak- en wilde diere dien, is die suksesvolle diagnose 
van M. bovis-geïnfekteerde diere noodsaaklik om die verspreiding van die siekte te kan beheer. 
Daar word egter nog steeds geglo dat die diagnostiese toetse wat gebruik word gedurende bTB-
beheerprogramme, soos die enkele intradermale vergelykende tuberkulien-toets (“single 
intradermal comparative tuberculin test”; SICTT) en kommersieel beskikbare interferon-
gamma-vrystellingstoetse (“interferon gamma release assays”; IGRA’s), nog steeds 
suboptimaal is vir die diagnose van bTB in beesverwante hoefdiere. ǹ Moontlike benadering 
tot die verbetering van sulke toetse mag dalk die gebruik wees van nuwe antigene of die 
identifisering van alternatiewe of aanvullende biomerkers anders as interferon-gamma (IFN-
γ). Hierdie proefskrif bespreek studies wat ontwerp is om nuwe en oorspronklike benaderings 
te identifiseer, te ontwikkel en te evalueer met die doel om die diagnose van M. bovis-infeksie 
in Kaapse buffels te verbeter. 
Die eerste doelwit was om die diagnostiese potensiaal van twee nuwe, beskikbare, kommersiële 
IGRA’s, die Bovigam® PC-EC-toets en die Bovigam® PC-HP-toets, vir die eerste keer in 
buffels te evalueer, asook om hulle prestasie te vergelyk met diè van ǹ gemodifieerde mens-
IGRA (“modified QuantiFERON® TB-Gold (mQFT) assay”). Verder is die uitwerking van ǹ 
verlengde inkubasietyd van bloed op die sensitiwiteit van die mQFT-toets bepaal, asook die 
noodsaaklikheid van sentrifugering voor isolering van die plasmafraksie van die bloed. ǹ 
Opvolgstudie het die relatiewe sensitiwiteit van die Bovigam-toetse, ǹ gemodifiseerde 
Bovigam-toets en die SICTT in geïdentifiseerde M. bovis-geïnfekteerde buffels vergelyk. Die 
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gebruik van hierdie toetse in kombinasie is ook geëvalueer in ǹ poging om die optimale 
toetsalgoritme vir die diagnose van M. bovis-geïnfekteerde buffels te identifiseer. Kommersieel 
beskikbare bees-ELISA’s, asook ǹ mens-IP-10-ELISA is verder gebruik om geselekteerde 
kandidaatbiomerkers van M. bovis-spesifieke immuunaktivering te identifiseer, en om hulle 
diagnostiese potensiaal te evalueer.  Laastens het hierdie studie ook bepaal wat die uitwerking 
van die stoor van bloedplasma onder verskillende omstandighede op die diagnostiese 
potensiaal van die gebruik van IP-10-toetse in buffels sal wees. 
Ooreenstemming tussen die Bovigam® PC-EC- en die Bovigam® PC-HP-toetse was hoog (κ = 
0.86, 95% CI 0.75–0.97) en hierdie toetse het die hoogste aantal toetspositiewe diere 
geïdentifiseer, wat aandui dat hulle die mees sensitiewe toetse was. Ooreenstemming tussen 
die mQFT-toetse was ook hoog (κ=0.88, 95% CI 0.77-0.98). Alle buffels met verskillende 
mQFT-resultate (n=6), asook 3 definitiewe M. bovis-geïnfekteerde diere, was egter positief na 
30 uur inkubasie, maar negatief na 20 uur. Hierdie resultate impliseer dat die mQFT-toets die 
mees sensitiewe van die twee is wanneer langer inkubasieperiodes gebruik word. Verder is 
daar ook geen betekenisvolle verskil in IFN-γ-konsentrasies waargeneem tussen 
plasmafraksies geïsoleerd vanaf QFT-buise voor en na sentrifugering nie. Hierdie bevinding 
beteken dat verskillende inkubasieperiodes in ǹ poging om die toetssensitiwiteit te verbeter, 
aanvaarbaar is. Wanneer die betroubaarheid van die IFN-γ-toetse vergelyk is in buffels, het die 
Bovigam PPD-toets ǹ relatiewe sensitiwiteit van tussen 91-93% getoon, terwyl die sensitiwiteit 
van die gemodifieerde PPD-toets tussen 90-91% was. Diagnostiese sensitiwiteit is verder 
verbeter deur een of meer IGRA’s met die SICTT te kombineer (95-100%). Verdere navorsing 
oor alternatiewe biomerkers anders as IFN-γ in ǹ poging om die sensitiwiteit van IGRA’s te 
verhoog, het getoon dat IP-10-vlakke ǹ betekenisvolle verhoging in antigeen-gestimuleerde 
bloedmonsters van M. bovis-geïnfekteerde buffels toon (p < 0.0001). Daar is ook aangetoon 
dat IP-10 in groter hoeveelhede as IFN-γ geproduseer is, ǹ eienskap wat grootliks kan bydra 
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tot IP-10 se potensiaal as ǹ nuwe biomerker vir die diagnose van bTB in buffels. In aansluiting 
hierby is vasgestel dat deur IP-10 te gebruik, daar ǹ verbetering in ooreenstemming 
waargeneem is tussen die mQFT-toets en die Bovigam-toetse, terwyl die uitstekende 
ooreenstemming tussen die Bovigam-toetse onveranderd gebly het. Aangesien die vervoer en 
stoor van buffelbloed ǹ belangrike aspek is om by die ontwikkeling van diagnostiese toetse vir 
bTB in ag te neem, is die uitwerking van hitte-inaktivering en die stoor van plasma op 
proteïenstoorkaarte (“protein saver cards”; PSC’s) op IP-10 se betroubaarheid as biomerker 
ondersoek. Daar is vasgestel dat die inkubasie van bloedplasma teen 65 °C vir 20 min geen 
betekenisvolle vernietiging van IP-10 getoon het nie en dat IP-10 nog steeds suksesvol gemeet 
kon word in plasma nà storing op PSC’s vir 2 weke en 8 weke onderskeidelik. Verder het IP-
10 uitstekende diagnostiese potensiaal onder alle stoortoestande behou. 
Die onbeskikbaarheid van spesiesspesifieke immunologiese reagense beperk diagnostiese 
toetse vir bTB in wild grootliks. Verder is die validering van diagnostiese toetse, deur die 
gebruik van nuwe biomerkers soos IP-10, bemoeilik deur sekere logistieke beperkings. Sulke 
beperkings sluit in: 1) beperkte dieregetalle in ǹ studie wat die akkurate berekeninge van ǹ 
toepaslike afsnypunt vir IP-10 kan benadeel; 2) die gebruik van antigeenspesifieke 
toetsprotokolle vir bloedinkubasie wat alleenlik geoptimiseer is vir die meting van IFN-γ en 
nie noodwendig vir IP-10 nie, en 3) die gebrek aan nadoodse monsters vir die bevestiging van 
M. bovis-infeksie in Bovigam-negatiewe IP-10-positiewe buffels. 
Ten slotte, die Bovigam® PC-EC-toets en die Bovigam® PC-HP-toets was meer sensitief as 
albei die SICTT- of die mQFT-toetse in hulle huidige formaat. Bloedplasma verkry vanaf die 
QFT-buise voor sentrifugering kon met vertroue gebruik word in die mQFT-toets. Verlenging 
van die inkubasietyd van bloed in die QFT-buise van 20 uur tot 30 uur, het gelei tot die 
aansienlike verbetering van die mQFT-toets se sensitiwiteit. Volgens die resultate van ǹ 
aanvullende studie het die Bovigam PPD-toets, asook ǹ gemodifiseerde PPD-toets die beste 
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sensitiwiteit vir die identifisering van M. bovis-geïnfekteerde buffels getoon. Die SICTT het 
addisionele IGRA-negatiewe diere geïdentifiseer en die hoogste sensitiwiteit is bereik wanneer 
hierdie toetse in kombinasie gebruik is. Addisioneel tot IFN-γ, wil dit ook voorkom of IP-10 
as ǹ nuttige merker van immuunaktivering in buffels kan dien deur gebruik te maak van ǹ IP-
10-bees-ELISA, wat kommersieel beskikbaar is. IP-10 toon verder goeie potensiaal as ǹ 
diagnostiese biomerker in M. bovis-geïnfekteerde buffels en die gebruik daarvan dui ook op ǹ 
verhoging in die sensitiwiteit van konvensionele IGRA’s. IP-10 kon suksesvol gemeet word in 
plasma gestoor op PSC’s, alhoewel die sensitiwiteit verminder het met ǹ verlengde 
stoortydperk in die toetse op hierdie monsters. Plasma verhit tot 65 ºC vir 20 min het geen 
degradering van IP-10 getoon nie en hierdie eienskap is ǹ verdere demonstrasie van die 
hittestabiliteit van hierdie sitokien.  
Hierdie bevindinge word ondersteun deur vorige studies in beeste wat die gesamentlike gebruik 
van die SICTT- en die Bovigam PPD-toets sterk aanbeveel. Die huidige studie het ook grootliks 
die potensiaal van IP-10 vir die diagnose van bTB in die Kaapse buffel beklemtoon. Die 
verbetering in sensitiwiteit van M. bovis-spesifieke IGRA’s, deur die gebruik van IP-10, is ǹ 
betekenisvolle voordeel van die gebruik van hierdie sitokien as voorkeurbiomerker in hierdie 
spesie. ǹ Verdere voordeel van diè sitokien is sy hittetoleransie en stabiliteit op PSC’s. Hierdie 
nuttige eienskappe mag daarop dui dat diagnostiese monsters veilig vervoer kan word deur 
potensiële patogene in die plasma deur hitte te inaktiveer, of deur alternatiewelik gebruik te 
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Chapter 1 – General Introduction 
Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB) in many free-ranging 
mammals, captive wildlife and livestock (1). This species forms part of the Mycobacterium 
tuberculosis complex (MTC) that consists of a genetically related group of bacteria that can 
cause tuberculosis in humans or many other species (2–4). M. bovis is known to have the widest 
host range of all the MTC bacteria (5) and infections have previously been reported in more 
than 60 mammal species worldwide (6). Garnier et al., (2003) reported a worldwide annual 
loss to agriculture of $3 billion due to the increasing wildlife-livestock-human interfaces. In 
Africa, buffaloes (Syncerus caffer) are one of the most important maintenance hosts of bTB 
and spill-over of this pathogen to other wildlife or domestic cattle may not only result in 
reduced productivity or death of these animals (7), but also poses a serious zoonotic risk. In 
South Africa, the spill-over from infected buffaloes to other wildlife species may occur through 
predation, scavenging or contaminated environments (8). The occurrence of wildlife reservoirs 
of bTB such as African buffaloes, European badgers (Meles meles), brush-tail possum 
(Trichosurus vulpecula) and white-tailed deer (Odocoileus virginianus) complicates the 
eradication of this disease by posing a threat for reinfection of livestock (1).  
Following infection with M. bovis, animals mount a cell mediated immune (CMI) response. 
This response is mediated by activated antigen-specific T-lymphocytes that might function as 
effector cells, orchestrate an inflammatory reaction, or recruit cells such as monocytes, 
neutrophils, macrophages, dendritic cells through secretion of certain cytokines. Key cytokines 
include interferon gamma (IFN-γ), interleukin (IL)-2, tumour necrosis factor (TNF)-α and 
TNF-β (9). The host response in the infected animal is a balance between effective 
inflammatory and immunological responses that contain and eliminate pathogens while 
minimizing tissue damage. Pro and anti-inflammatory cytokines play an essential role in 
Stellenbosch University  https://scholar.sun.ac.za
2 
 
mediating the outcome of the host’s response to pathogenic mycobacteria and pathogenesis of 
disease (10).  
bTB is a chronic progressive disease and animals may be infected for months or years before 
developing lesions in affected tissues (11). Disease outcome in M. bovis infected animals is 
variable, and influenced by host species, behaviour, age, route of infection, infectious dose, 
concurrent disease states, and environmental conditions (12). In cattle, the most common routes 
of exposure are inhalation of aerosols containing M. bovis bacilli from infected animals or 
contact with contaminated pastures and/or water (13). Although typically asymptomatic in 
early infection, animals that develop advanced disease may show clinical signs such as 
coughing, debilitation, emaciation, and lagging behind the herd (14). For cattle and buffaloes, 
tuberculous lesions occur primarily in the thoracic cavity, specifically in the lungs, bronchial 
and mediastinal lymph nodes (15,16). Other commonly affected areas include lymphoid tissue 
in the head region such as the retropharyngeal lymph nodes, submandibular lymph nodes and 
tonsillar tissue (12,16). The slow development of lesions and location makes direct ante-
mortem detection of M. bovis challenging.  This complicates arriving at a definitive diagnosis 
of bTB, which is important for disease management and control.   
Current control strategies in South Africa aim to effectively manage and prevent the spread of 
bTB in livestock by using a test and slaughter program (17). The program relies primarily on 
the single comparative intradermal tuberculin test (SCITT), a test that measures a delayed type 
hypersensitivity response following the intradermal injection of mycobacterial-specific 
antigens, i.e. M. bovis purified protein derivative (PPDbov) and M. avium-PPD (PPDav). 
Animals that react to PPDbov in this test are culled from the herd. Changes in skin thickness 
are measured three days after tuberculin injection of either the caudal fold (CFT) or opposite 
sides of the neck (SICTT). A positive skin test result is determined by an increase of 4 mm or 
greater in skin fold thickness (SFT) measurements at the PPDbov injection site compared to 
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the PPDav site at 72 hours.  If the differential measurement is between 2 mm and 4 mm, the 
animal is considered to have a suspect test result (18). Even though the SICTT reportedly lacks 
both sensitivity and specificity (19,20), countries such as New Zealand, Australia and the 
U.S.A. have effectively controlled bTB in their livestock using tuberculin skin testing as the 
basis of their programs (21,22). This approach is complicated in countries such as South Africa 
and the U.K. where there are free-ranging maintenance hosts of this disease (23,24).  
The SICTT has been used in African buffaloes for over 20 years, although not formally 
validated in this species (25). Unlike cattle, buffaloes require two chemical immobilizations to 
perform this test; once when administrating the injections and again when reading the dermal 
reactions. Buffaloes are typically confined to bomas for at least three days to minimize the cost 
and time associated with recapture. For wild animals such as buffaloes, the consequences of 
confinement are increased stress, risk of trauma, and possibly death. Furthermore, 
immunological sensitization to PPD antigens may occur following the SICTT, which prevents 
repeat testing for at least 90 days to avoid false positive reactions. Regulations require that any 
buffalo that will be moved to have a negative skin test.  However, if there are reactors in a herd, 
retesting is necessary to confirm sequential negative results, leading to long delays before 
transport can occur. Extended confinement and prolonged testing has been highly problematic 
for the wildlife industry and conservation programs (19). 
Due to the costs, risks to animals and staff, and logistical constraints of using the tuberculin 
skin test, novel diagnostic strategies are needed to effectively manage and prevent the spread 
of M. bovis in wildlife and livestock. One strategy would be early detection of infected animals, 
ideally prior to a stage in which they start shedding, to prevent the transmission to other animals 
and geographic spread of disease by natural or intentional movement of animals (26,27). One 
such way is use of the interferon-gamma (IFN-γ) release assay (IGRA) that measures the in 
vitro secretion of IFN-γ by lymphocytes in response to pathogen-specific antigen stimulation. 
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IGRAs quantify the production of IFN-γ in plasma supernatant using a sandwich enzyme-
linked immunosorbent assay (ELISA) that utilizes either species-specific or cross-reactive 
monoclonal or polyclonal anti-IFN-γ antibodies (20). IGRAs have been shown to be more 
sensitive than the SICTT and have the added advantages of rapid results (usually within 24 
hours) and single handling of the animal (20,28).  A commercial IGRA, the Bovigam® assay 
(Prionics), is currently used as an ancillary test to the SICTT for the detection of bTB infection 
in cattle (29). Limitations of the Bovigam® assay, which uses PPDs as test antigens, are higher 
cost, logistical constraints such as sample handling for the incubation of blood in 96 well plates, 
and in return for high sensitivity, reduced specificity (30,31). More recently, the specificity of 
this IGRA has been improved by the inclusion of M. bovis-specific peptides, such as the 6 kDa 
early secretory antigenic target (ESAT-6) and the 10 kDa culture filtrate protein (CFP-10), both 
highly expressed by M. bovis and M. tuberculosis, but absent from M. bovis Bacillus Calmette-
Guérin (BCG) strains and other non-tuberculous mycobacteria (29,32). Similarly, a human TB 
test, the QuantiFERON TB-Gold assay (Qiagen), which utilizes ESAT-6 and CFP-10, has been 
modified for bTB diagnosis in African buffaloes and has been shown to be a practical 
alternative to the Bovigam® assay (27). However, IGRAs are still believed to be suboptimal 
for bTB diagnosis in bovids (11).  Therefore, identification of biomarkers other than IFN-γ, 
either as alternatives or ancillary markers of bTB infection, may increase the sensitivity of M. 
bovis-specific assays (33–36).  
In humans, candidate immunological biomarkers of M. tuberculosis infection include the 
chemokine IFN-γ-induced protein 10 (IP-10) (37), monokine induced by IFN-γ (MIG) (38,39), 
monocyte chemoattractant protein (MCP)-1, MCP-2, MCP-3 and IL1-receptor antagonist (IL1-
RA) (37,39). In patients with active tuberculosis, Ruhwald et al. (2009) reported significantly 
higher concentrations of IP-10, IL1-RA, MCP-1, MCP-2 and MCP-3 compared to IFN-γ in M. 
tuberculosis-antigen stimulated whole blood, showing the diagnostic potential of all five 
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biomarkers for TB infection.  In this study, IP-10 and MCP-2 were the most promising 
cytokines. Furthermore, IP-10 has been shown to be a very stable protein in human blood 
plasma, stored at room temperature, as well as dried on filter membrane paper and transported 
via conventional postal services (40,41). MIG has also been identified as a novel biomarker of 
TB infection in a study of BCG-vaccinated controls and TB patients (38). There was a 
significant correlation between MIG and IFN-γ concentrations in these patients.  In cattle, 
antigen-induced mRNA expression of IP-10, MIG, Granzyme A and IL-22 suggests that these 
immunological markers may have value for detection of M. bovis infection. However, IP-10 
was a poor indicator of immunological responses in M. bovis experimentally infected cattle 
using a human IP-10 ELISA (42,43). 
In summary, bTB is a chronic and progressive disease that may be undetected for months or 
years before visible lesions develop in affected tissues. The disease is maintained by free 
ranging wildlife reservoirs such as African buffaloes that pose an infection risk to livestock 
and other animals. Therefore, the focus should be early diagnosis of bTB in buffaloes to 
minimize transmission and spread of disease. However, this goal is confounded by the lack of 
accurate practical tools for testing buffaloes.  
Therefore, the present study aimed to investigate a number of approaches for improving the 
diagnosis of M. bovis infection in African buffaloes. These included the evaluation of new 
stimulation antigens for the Bovigam® assay, Peptide Cocktail Prionics® PC-EC and Peptide 
Cocktail Prionics® PC-HP; an estimation and comparison of diagnostic sensitivity of selected 
CMI assays; identification of novel biomarkers of M. bovis infection; assessment of the 
diagnostic performance of interferon-gamma induced protein-10 (IP-10) and investigation of 
IP-10 stability during storage and transport. 
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We assessed the use of M. bovis-specific peptides for the diagnosis of tuberculosis in African 
buffaloes (Syncerus caffer) by evaluating the agreement between the single intradermal 
comparative tuberculin test (SICTT), the Bovigam® EC (BEC) assay, the Bovigam® HP (BHP) 
assay and 2 assays utilizing the QuantiFERON® TB-Gold (in tube) system employing 20 h 
(mQFT20 assay) and 30 h (mQFT30 assay) whole blood incubation periods. Of 84 buffaloes, 
45% were SICTT-positive, 48% were BEC-positive, 50% were BHP-positive, 37% were 
mQFT20-positive and 43% were mQFT30-positive. Agreement between the BEC and BHP 
Bovigam® assays was high (κ=0.86, 95% CI 0.75-0.97) and these detected the most test-
positive animals suggesting that they were the most sensitive assays. Interferon-gamma release 
was significantly greater in buffaloes that were test-positive for all tests than in animals with 
discordant but positive Bovigam® results. Agreement between the mQFT assays was equally 
high (κ=0.88, 95% CI 0.77-0.98); however, all buffaloes with discordant mQFT results (n=6) 
were mQFT30-positive/mQFT20-negative, including 3 confirmed M. bovis-infected animals, 
suggesting that the mQFT30 assay is the more sensitive of the two. Agreements between the 
two Bovigam® and two mQFT assays were moderate, suggesting that in its current format the 
mQFT assay is less sensitive than either the BEC or BHP assays. 
Keywords: 
African buffalo, Bovigam®, bovine tuberculosis, CFP-10, ESAT-6, interferon-gamma. 
  




Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) and has a wide host 
range including cattle and various wildlife species (Michel et al., 2006). In cattle, BTB may 
cause reduced productivity and death but also poses an important zoonotic risk and the disease 
is therefore intensively controlled in many countries. In South Africa, African buffaloes 
(Syncerus caffer) are an important maintenance host of M. bovis and may act as a reservoir of 
this pathogen for cattle and other wildlife species such as lions (Panthera leo) (De Vos et al., 
2001). Therefore, the detection of M. bovis-infected buffaloes is important in preventing the 
transmission of BTB to other species, including domesticated livestock, as well as the 
geographic spread of this pathogen through movement of infected animals (Grobler et al., 
2002; Parsons et al., 2011). 
Since BTB is a chronic and progressive disease, animals may be infected for months or years 
before developing lesions and early diagnosis relies primarily on the detection of cell mediated 
immunity (CMI) to M. bovis antigens (Vordermeier et al., 2000). Examples of such tests 
include the single intradermal comparative tuberculin test (SICTT) and the interferon gamma 
(IFN-γ) release assays (IGRA). These tests have historically measured CMI to M. bovis purified 
protein derivative (PPD) which comprises a broad range of M. bovis antigens. More recently, 
the specificity of IGRAs have been improved by the development of assays which detect 
immunological sensitization to M. bovis-specific antigens such as the 6 kDa early secretory 
antigenic target (ESAT-6) and the 10 kDa culture filtrate protein (CFP-10) (Vordermeier et al., 
1999; Vordermeier et al., 2001; Bass et al., 2013). Genes encoding these proteins are located 
in the genetic region of difference 1 (RD1) which is absent from most nontuberculous 
mycobacteria and the attenuated strain of M. bovis, Bacillus Calmette-Guérin (Vordermeier et 
al., 2001).  
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A modification of a human TB test, the modified QuantiFERON® TB-Gold  (mQFT) assay, 
which utilises peptides simulating the proteins ESAT-6, CFP-10 and TB 7.7, has been 
described for the diagnosis of BTB in buffaloes (Parsons et al., 2011). However, the use of two 
newly available commercial Bovigam® assays which employ ESAT-6 and CFP-10 peptides 
(EC), and these together with peptides simulating Rv3615 and 3 additional mycobacterial 
antigens (HP), has not been reported in this species. 
We therefore wished to evaluate the use of the Bovigam® EC (BEC) and Bovigam® HP (BHP) 
assays to detect M. bovis-infected buffaloes. Furthermore, we evaluated the effect of increased 
blood incubation time on the sensitivity of the mQFT assay, and as part of this study, assessed 
whether centrifugation of the QFT tubes, as previously reported (Parsons et al., 2011), was a 
necessary step prior to harvesting plasma supernatants. Finally, because mycobacterial culture 
is regarded as an imperfect gold standard of infection (de la Rua-Domenech et al., 2006), and 
because this data was not available for all tested animals, we characterized the agreement 
between the Bovigam® assays, the mQFT assays and the SICTT.  
Material and Methods 
Animals and SICTT: 
Two hundred and thirty-one buffaloes from two herds (herd A and B) with known BTB 
exposure were captured during a test-and-slaughter control program in the Hluhluwe-iMfolozi 
Game Reserve (South Africa) and tested as previously described (Parsons et al., 2011). 
Following measurement of the skin fold thickness (SFT) at injection sites, 0.1 ml M. bovis PPD 
and 0.1 ml M. avium PPD (WDT, Hoyerhagen, Germany) were injected intradermally on the 
left and right side of the neck, respectively. After 3 days, the SFT was measured with callipers 
in all animals with palpable inflammation at the injection sites. SICTT-positive animals were 
defined as having an SFT increase at the M. bovis PPD injection site of 2 mm or greater than 
that at the M. avium PPD injection site. Eighty-four animals from Herd A (n=144) were 
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randomly selected to assess the agreement between the various diagnostic tests while all 
animals from Herd B (n=87) were used to compare the concentration of IFN-γ in QFT plasma 
samples before and after centrifugation. Ethical approval for this study was granted by the 
Stellenbosch University Animal Care and Use committee.   
mQFT, BEC and BHP assays: 
Ten ml of blood was drawn from each animal into heparinised blood collection tubes by 
venepuncture of the jugular vein. For all animals, 1 ml of blood was incubated for 20 h at 37ºC 
in the blood collection tubes of the QFT system (Qiagen, Venlo, Limburg, Netherlands), i.e. 
the Nil tube containing saline and TB Antigen tube containing ESAT-6, CFP-10 and TB7.7 
peptides. Thereafter, for animals from Herd B, 150 μl of plasma was harvested from each tube. 
Tubes were then centrifuged at 1000 x g for 6 min and the remaining plasma was collected. 
For animals from Herd A, 150 μl of plasma was collected without centrifugation from each 
QFT tube and the tubes were further incubated for 10 h at 37ºC. Thereafter, tubes were 
centrifuged (as above) and the remaining plasma was collected. Plasma IFN-γ concentrations 
were determined using a bovine IFN-γ enzyme linked immunosorbent assay (ELISA) 
according to the manufacturer’s instructions (kit 3115-1H-20; Mabtech, AB, Nacka Strand, 
Sweden). For the mQFT assays, a cut-off of 66 pg/ml was used to identify positive animals, as 
previously described (Parsons et al., 2011). Tests performed with plasma collected after 20 h 
incubation and after a further 10 h incubation (30 h in total) were defined as mQFT20 and 
mQFT30, respectively. 
All buffaloes from Herd A were tested with the BEC and BHP assays (Prionics, Schlieren-
Zurich, Switzerland). The assays were performed according to the manufacturer’s instructions 
with the following exceptions: because incubation was performed in a non-sterile incubator, 
whole blood samples were incubated in sealed 2 ml microcentrifuge tubes rather than tissue 
culture plates, and samples were centrifuged at 1000 x g for 6min prior to plasma collection. 
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Post mortem examination and mycobacterial culture: 
All SICTT-positive animals and a single SICTT-negative/Bovigam®-positive/mQFT30-
positive animal were killed by gunshot and inspected at necropsy for evidence of gross BTB 
lesions. The tonsils, retropharyngeal, parotid and sub-mandibular lymph nodes, the left- and 
right bronchial lymph nodes and lungs were excised and multiple parallel incisions were made 
into these tissues. Samples collected for mycobacterial culture included lesions suggestive of 
BTB, or if no such lesion was present, pooled samples from the bronchial and retropharyngeal 
lymph nodes. Tissue was homogenized (Bullet blender, Next Advance, Averill Park, NY, 
USA) after which 5ml BD MycoPrep™ (Becton Dickinson, Franklin Lakes, NJ, USA) was 
added to each 1 cm3 of sample and incubated for 15 min at 37ºC. Thereafter, samples were 
neutralized with 5ml phosphate buffered saline (PBS). All samples were centrifuged for 15 min 
at 1000 x g and the supernatant decanted. Each pellet was resuspended in 1 ml PBS and 500 μl 
of this suspension was transferred to a Mycobacteria Growth Indicator Tube (MGITTM) and 
incubated in a BACTEC™ MGIT™ 960 Mycobacterial Detection System (both Becton 
Dickinson). Cultures which were ZN-positive were genetically speciated by polymerase chain 
reaction as previously described (Warren et al., 2006). 
Statistical analysis: 
For Herd A, the agreement between each of the diagnostic assays was calculated as Cohen’s 
Kappa coefficient (κ) using the agreement calculator on the GraphPad Software website 
(http://graphpad.com/quickcalcs/kappa1/). For Herd B, plasma IFN-γ concentrations in pre- 
and post-centrifuged QFT samples were compared in SICTT-negative and -positive animals 
using a nonparametric paired student’s t-test using GraphPad Prism version 5 (GraphPad 
Software, March 2007).  
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Results & Discussion 
There were no significant differences in IFN-γ concentrations in plasma samples harvested 
from QFT tubes prior to and after centrifugation from SICTT-negative (n=70) and SICTT-
positive (n=17) buffaloes (Fig 1). Additionally, mQFT results for these animals were identical 
for both methods (data not shown). This indicates, as for human samples 
(http://www.cellestis.com/IRM/content/aust/qftproducts_tbgoldintube_faqs.html), that buffalo 
plasma collected from the QFT tubes without centrifugation can reliably be used in the mQFT 
assay.  
 
Fig 1.  Mean IFN-γ concentrations (and 95% confidence intervals) in plasma from Nil and TB 
antigen QuantiFERON®-TB Gold tubes from a) SICTT-negative (n = 70) and b) SCITT-
positive (n = 17) buffaloes showing no significant difference between samples collected before 
and after centrifugation (p > 0.1). 
 
Of the 84 buffaloes tested with all diagnostic assays, 38 (45%) tested positive with the SICTT, 
31 (37%) with the mQFT20 assay, 36 (43%) with the mQFT30 assay, 41 (48 %) with the BEC 
assay and 42 (50%) with the BHP assay. Of these, 29/84 (35%) tested positive for all tests, 
36/84 (43%) tested negative for all tests and 19/84 (22%) had discordant test results (Table 1 
and Supplementary Table 1 under Appendix I). Mycobacterium bovis infection was confirmed 
by mycobacterial culture and genetic speciation following post mortem examination in 27/34 
SICTT-positive buffaloes and 1 BEC/BHP/mQFT30-positive animal which tested negative 
with the SICTT and the mQFT20 assays (animal A67, Table 1 and Supplementary Table 1  
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under Appendix I). 
The agreement between the two Bovigam® assays was very good (κ=0.86, 95% CI 0.75-0.97, 
Table 2), however, the limitations of this study precluded confirmation of M. bovis infection in 
9 BEC- and BHP-positive animals. Nonetheless, the excellent agreement between these assays 
Table 1 
Test results for African buffaloes with discordant bovine tuberculosis test outcomes. 
Animal 













A1 +i 0.158 + 0.131 - 16 - 57 - n.d. j 
A8 -k 0.05 + 0.17 - 0 - 17 - n.d. 
A26 + 2.262 + 2.192 + 1192 - 0 + + 
A30 - 0.042 - 0.091 - 46 - 35 + - 
A32 + 0.15 + 0.206 - 0 - 0 - n.d. 
A33 + 0.26 + 0.165 - 0 - 11 - n.d. 
A34 + 0.095 + 0.098 - 0 - 20 - n.d. 
A36 + 0.168 + 0.191 - 46 + 236 + + 
A41 + 0.643 - 0 - 14 - 0 - n.d. 
A42 + 0.253 + 0.184 - 36 + 74 + - 
A43 + 0.254 + 0.226 - 26 + 108 + + 
A48 - 0.065 - 0.057 - 44 - 3 + + 
A49 + 0.111 - 0.083 - 12 - 27 + + 
A50 + 0.393 + 0.41 - 1 - 2 - n.d. 
A52 - 0.085 - 0.073 - 45 - 41 + - 
A67 + 0.191 + 0.212 - 22 + 162 - + 
A68 - 0 + 0.288 + 191 + 549 + + 
A70 - 0.067 + 0.103 - 26 + 68 - n.d. 
A75 - 0.088 + 0.154 + 129 + 142 - n.d. 
A94 - 0.075 - 0.075 - 36 + 121 - n.d. 
a Bovigam® assay utilising peptides derived from ESAT-6 and CFP-10. 
b Bovigam® assay utilising peptides derived from ESAT-6, CFP-10, Rv3615 and 3 mycobacterial antigens. 
c modified QuantiFERON® TB-Gold assay (20 h blood incubation). 
d modified QuantiFERON® TB-Gold assay (30 h blood incubation). 
e Single intradermal comparative tuberculin test 
f Warren et al. (2006). 
g Optical density of the peptide stimulated sample minus that of the Nil sample. 
h IFN-γ concentration in the TB Antigen-stimulated sample minus that in the Nil sample  
I Positive. 
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suggests that they may indicate true infection and that they were the most sensitive detection 
methods used in this study. Furthermore, the BHP assay yielded the greatest number of positive 
tests, and may be more sensitive than the BEC, in agreement with the manufacturer’s guidelines 
for cattle (http://www.prionics.com/diseases-solutions/tuberculosis/bovigamR-2g/). Notably, 
for both assays, the amount of IFN-γ release was significantly greater in buffaloes that were 
test-positive for all tests than in animals with discordant test results (Fig. 2). Higher levels of 
IFN-γ release in response to ESAT-6 and CFP-10 stimulation have been shown to correlate 
with increased pathology in cattle (Vordermeier et al., 2002) and the buffaloes with discordant 
test results may therefore represent a group of animals with early infection or limited disease 
progression. These interpretations of our results should be investigated in future studies in  
which BEC- and BHP-positive animals are examined at post mortem for evidence of M. bovis 
infection and disease. 
Table 2 
The Kappa (κ) and 95% confidence interval estimates of agreement between five tests for bovine 
tuberculosis in African buffaloes (n=84).  
 SICTTa mQFT20b mQFT30c BHPd BECe 
SICTT 1 0.78 (0.65-0.91) 0.81 (0.68-0.93) 0.72 (0.57-0.86) 0.76 (0.62-0.90) 
mQFT20 0.78 (0.65-0.91) 1 0.88 (0.77-0.98) 0.74 (0.60-0.88) 0.69 (0.54-0.84) 
mQFT30 0.81 (0.68-0.93) 0.88 (0.77-0.98) 1 0.81 (0.69-0.93) 0.71 (0.56-0.86) 
BHP 0.72 (0.57-0.86) 0.74 (0.60-0.88) 0.81 (0.69-0.93) 1 0.85 (0.75-0.97) 
BEC 0.76 (0.62-0.90) 0.69 (0.54-0.84) 0.71 (0.56-0.86) 0.85 (0.75-0.97) 1 
a single intradermal comparative tuberculin test. 
b modified QuantiFERON® TB-Gold assay (20 h blood incubation). 
c modified QuantiFERON® TB-Gold assay (30 h blood incubation). 
d Bovigam® assay utilising peptides derived from ESAT-6, CFP-10, Rv3615 and 3 mycobacterial 
antigens. 
e Bovigam® assay utilising  peptides derived from ESAT-6 and CFP-10. 
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As expected, agreement between the mQFT20 and mQFT30 assays was equally high (κ=0.88, 
95% CI 0.77-0.98, Table 2). However all animals with discordant mQFT results were 
mQFT30-positive and mQFT20-negative (n=6; Table 1). Five of these were BHP-positive and 
3 were confirmed to be M. bovis-infected at post mortem (Table 1). However, a single 
mQFT20-negative/mQFT30-positive animal (A94) tested negative for all other tests (Table 1). 
Notably, Min et al. (2013) showed that in healthy human controls the number of QFT-positive 
individuals increased from 2/33 to 4/33 when the duration of blood incubation was increased 
from 24 to 48 h. However, in patients with suspected tuberculosis, the sensitivity of the QFT 
assay decreased when the duration of QFT blood incubation was increased from 24 to 48 and 
72 h (Min et al., 2013). Our findings on the increased incubation time are confounded by the 
concurrent reduction in plasma volume in the mQFT30 assay during the last 10 h of incubation. 
In itself, this lower plasma volume may have allowed for the accumulation of a higher IFN-γ 
concentration in antigen-stimulated samples. Nonetheless, although specificity of the assay 
may be compromised, our findings suggest that increasing the duration of blood incubation in 
IGRAs may increase the sensitivity of this assay in buffaloes and should be further investigated. 
Fig 2. Test results for (a) the Bovigam® EC assay, and (b) the Bovigam® HP assay for buffaloes 
with concordant and discordant SICTT, mQFT20 and mQFT30 test results showing mean and 
95% confidence intervals. *, p < 0.001. 
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The moderate agreement between the two Bovigam® and two mQFT assays was surprising 
(Table 2). Interpretation of this finding is speculative given the proprietary nature of their 
components, however it may in part be attributable to differences in the sensitivities of the 
ELISAs used in each assay and improvement of the mQFT ELISA might increase its utility. 
Furthermore, in humans, Gaur et al. (2013) showed that reducing the volume of blood in QFT 
tubes increases the sensitivity of this assay, possibly as a result of the increased antigen 
concentration in the blood sample. Indeed, higher TB antigen concentrations have been shown 
to result in greater IFN-γ release in IGRAs (Rose et al., 2013). Any difference in the 
concentrations of antigenic peptides in the Bovigam® and mQFT assays may have resulted in 
differences in their sensitivities. Reducing the volume of blood incubated in the QFT tubes 
might therefore increase the sensitivity of this assay. Additionally, the QFT assay has been 
specifically developed for TB diagnosis in humans and presumably utilizes ESAT-6 and CFP-
10 peptides which are immunodominant in this host (Mustafa et al., 2008; Arlehamn et al., 
2012). However, a different set of such peptides is immunodominant in cattle (Vordermeier et 
al., 1999, 2000, 2001) and differences in the composition of the ESAT-6/CFP-10 peptide 
cocktail of the mQFT and Bovigam® assays may have contributed towards the observed 
discrepancies in test results. 
In conclusion, this study shows that plasma collected from the QFT tubes prior to centrifugation 
can reliably be used in the mQFT assay and that increasing the incubation time of this assay 
from 20 to 30 h may increase its sensitivity. This is also the first report of the use of the 
Bovigam® peptide assays for the diagnosis of BTB in buffaloes and our findings suggest that 
these assays are more sensitive than either the SICTT or mQFT in its current format. 
Nonetheless, the mQFT assay remains a highly practical test for BTB in buffaloes, especially 
under field conditions (Parsons et al., 2011), and improvements to this assay, as discussed 
above, may increase its utility. 
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In South Africa, African buffalo (Syncerus caffer) are a major maintenance host of 
Mycobacterium bovis, the cause of bovine tuberculosis (bTB), and may act as a source of this 
infection for domestic cattle. The control of bTB in buffaloes relies on the use of the single 
intradermal comparative tuberculin test (SICTT) and interferon gamma release assays 
(IGRAs). In this study we aimed to evaluate relative sensitivities of the SICTT, the Bovigam 
PPD assay, a modified Bovigam PPD assay, the Bovigam PC-EC assay and the Bovigam PC-
HP assay in M. bovis-infected animals and explore the possibility of using these tests in 
combinations to report the optimal algorithm for the detection of bTB in African buffaloes. Of 
these assays, the Bovigam PPD assay had a relative sensitivity between 91-93% and the 
modified PPD assay a relative sensitivity between 90-91%. Moreover, combining one or more 
IGRA together with the SICTT showed an overall diagnostic sensitivity between 95-100%. In 
conclusion, the Bovigam PPD and modified PPD assays displayed greatest sensitivity for the 
detection of M. bovis-infected buffaloes. Nonetheless, the SICTT detected additional IGRA-
negative animals and maximum sensitivity was attained when these assays were used in 
combination. 
Keywords: African buffalo, Bovigam®, bovine tuberculosis, diagnosis, Mycobacterium bovis, 
SICTT 
2. Introduction 
Mycobacterium bovis, the causative agent of bovine tuberculosis (bTB), has a wide host range 
that includes numerous wildlife and domestic species (Michel et al., 2006). The disease not 
only causes loss of productivity or death of infected animals but also poses an important 
zoonotic risk and is intensively controlled in many countries (Olmstead and Rhode, 2004). In 
South Africa, African buffaloes (Syncerus caffer) are a major maintenance host of M. bovis 
and may act as a source of infection for domestic cattle (Musoke et al., 2015) or other wildlife 
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species such as lions (Panthera leo) (Olivier et al., 2015). For this reason, the detection of M. 
bovis-infected buffaloes is important for preventing the transmission and geographic spread of 
this disease (Grobler et al., 2002; Parsons et al., 2011). However, animals may be infected for 
months or even years before developing detectable disease and early diagnosis relies primarily 
on tests that quantify the cell mediated immune response to M. bovis antigens (Vordermeier et 
al., 2000). 
The most commonly used tests are the tuberculin skin tests which measure the delayed-type 
hypersensitivity response to intradermal injection of purified protein derivative (PPD) derived 
from M. bovis (PPDbov). Of these, the most specific test is the single intradermal comparative 
tuberculin test (SICTT) which compares this response to that against Mycobacterium avium 
PPD (PPDav) (Schiller et al., 2010). Similarly, the in vitro Bovigam® PPD assay measures the 
comparative release of interferon gamma (IFN-γ) to these antigens in whole blood samples 
(Grobler et al., 2002).  However, in buffaloes, this assay displays reduced specificity and has 
been modified to include Mycobacterium fortuitum PPD (modified PPD assay) as an additional 
comparative antigen (A.L. Michel et al., 2011). The specificity of IGRAs have also been 
increased through the use of the antigens 6-kDa early secreted antigenic target (ESAT-6) and 
10-kDa culture filtrate protein (CFP-10) (Parsons et al., 2011). Peptides simulating these are 
utilized in the Bovigam PC-EC assay, while the Bovigam PC-HP assay utilizes these together 
with peptides simulating Rv3615 and 3 additional mycobacterial antigens (Goosen et al., 
2014). However, recent studies have reported conflicting results on the comparative 
sensitivities of these assays and the SICTT, in part, due to limitations in their design (Goosen 
et al., 2014; van der Heijden et al., 2016). 
In order to advance insight into the diagnosis of M. bovis infection in African buffaloes, we 
therefore aimed to compare the sensitivities of the Bovigam PPD assay, the modified PPD 
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assay, the Bovigam PC-EC assay, the Bovigam PC-HP assay and the SICTT, as well as 
combinations of these, in M. bovis infected animals. 
3. Material and methods 
3.1. Animals 
In 2015, 283 buffaloes from three herds (Herd A, B and C) with known exposure to M. bovis 
were captured and chemically immobilized, as previously described (Parsons et al., 2011), 
during an annual test-and-slaughter program in Hluhluwe-iMfolozi Game Reserve (HiP, South 
Africa). Following immobilization, 10 ml of heparinized whole blood was collected by jugular 
venepuncture. Ethical approval for the capture and testing of these animals was granted by the 
Stellenbosch University Animal Care and Use Committee. 
3.2. IGRAs 
All buffaloes were tested using three standard commercially available Bovigam® assays 
(Prionics, Schlieren-Zurich, Switzerland) according to the manufacturer’s instructions as well 
as a modified testing protocol of the Bovigam® PPD assay that includes the additional 
stimulation of whole blood with M. fortuitum PPD as previously described (A.L. Michel et al., 
2011). For each animal, 250 μl of whole blood was added to 2 ml microcentrifuge tubes 
(Eppendorf, Hamburg, Germany) containing, respectively, 25 μl solutions of: 1) phosphate 
buffer saline (PBS), 2) M. bovis PPD (Thermo Fisher Scientific Prionics AG, Schlieren, 
Switzerland) at a final concentration of 24 μg/ml, 3) Mycobacterium avium PPD  (Thermo 
Fisher Scientific Prionics AG, Schlieren, Switzerland) at a final concentration of 24 μg/ml, 4) 
M. fortuitum PPD (Tuberculosis Laboratory, Onderstepoort Veterinary Institute, South Africa) 
at a final concentration of 3.3 μg/μl, 5) peptides simulating ESAT-6 and CFP-10 (Bovigam® 
PC-EC stimulation antigen, Prionics, Schlieren-Zurich, Switzerland), 6) the above peptides 
together with peptides simulating Rv3615 and 3 additional M. bovis antigens (Bovigam® PC-
HP stimulation antigen, Prionics, Schlieren-Zurich, Switzerland) and 7) pokeweed mitogen 
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(PWM) (Sigma-Aldrich, St. Louise, MO, USA) at a final concentration of 5 μg/ml, 
respectively. Following incubation for 20 h at 37 ºC, each tube was centrifuged at 1500 x g for 
10 min and plasma fractions were harvested and stored at -80 ºC. For the standard commercial 
assays, test analyses were done according to the manufacturer’s instructions. For the modified 
Bovigam PPD protocol, the standard test criteria were used unless an animal was classified as 
M. fortuitum PPD responsive (ODM. fortuitum PPD – ODPBS ≥ 0.15). In such cases, an animal was 
defined as test-positive if ODM. bovis – ODPBS ≥ 0.2 as well as ODM. bovis – ODM. avium ≥ 0.2. 
3.3. SICTT 
Following blood collection, 0.1 ml M. bovis PPD and 0.1 ml M. avium PPD (WDT, 
Hoyerhagen, Germany) were injected intradermally on the left and right side of each animal’s 
neck, respectively. Seventy-two hours post PPD administration, the skin fold thickness (SFT) 
at injection sites of all animals that tested positive on any of the Bovigam assays, as well as 
animals with distinctly visible skin responses, was measured with Hauptner callipers (Kyron 
Laboratories, Benrose, South Africa). An animal with an increase of 2 mm or greater in SFT 
at the M. bovis PPD injection site compared to the M. avium PPD injection site was defined as 
SICTT-positive. 
3.4. Post mortem (PM) examination and mycobacterial culture 
All IGRA and SICTT-positive buffaloes were killed by gunshot and examined for gross bTB 
lesions at necropsy. The tonsils and retropharyngeal, parotid, sub-mandibular, trachea-
bronchial, mediastinal and prescapular lymph nodes as well as the lungs were excised and 
multiple incisions were made into these tissues. Gross pathological changes consistent with 
bTB were scored as follows: 0 – no visible lesions; 1 – one small (< 10 mm in diameter) focal 
lesion; 2 – several small focal (more than 1 lesion < 10 mm in diameter) or single large (> 10 
mm in diameter) lesion and 3 – multifocal or confluent lesions (Palmer et al., 2007). Tissue 
samples with bTB-like lesions were collected and stored separately. For animals with no visible 
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lesions, samples of head and thoracic lymph nodes were pooled by anatomical site. All tissue 
samples were processed for mycobacterial culture using Mycobacterial Growth Indicator 
Tubes (MGITTM) and the BACTECTM MGITTM 960 Mycobacterial Detection System (Becton 
Dickinson, Franklin Lakes, NJ, USA), previously described (Goosen et al., 2014). All Ziehl-
Neelsen positively stained bacterial cultures were genetically speciated by polymerase chain 
reaction as previously described (Warren et al., 2006). 
3.5. Statistical analysis 
The agreement between each diagnostic assay was calculated as Cohen’s kappa coefficient (k) 
using the freely available agreement calculator on the GraphPad Software website 
(http://graphpad.com/quickcalcs/kappa1/). M. bovis-infected animals were defined as 1) those 
confirmed to be M. bovis-infected by culture of the pathogen (stringent criterion); and 2) those 
confirmed to be either M. bovis culture-positive or having bTB-like lesions with a score of 2 
or greater (lenient criterion). Using both criteria, the relative sensitivity of each assay was 
calculated as the proportion of M. bovis-infected animals testing positive for a particular IGRA. 
Furthermore, the relative sensitivity of all possible test combinations was evaluated using both 
reference criteria. All analyses were done using GraphPad Prism version 5 (GraphPad 
Software, Inc., La Jolla, CA, USA). 
4. Results 
4.1. SICTT, IGRAs and Mycobacterial culture 
Of the 283 buffaloes, 50/283 (17.7%) tested positive with the Bovigam PPD assay, 49/283 
(17.3%) tested positive with the modified PPD assay, 44/283 (15.5%) tested positive for the 
SICTT and 43/283 (15.2%) tested positive for the PC-EC assay and PC-HP assay, respectively 
(Appendix III, Supplementary Table S1). Of these, 31/283 (10.9%) tested positive for all tests, 
220/283 (77.7%) tested negative for all tests and 32/283 (11.3%) had discordant test results. 
The PC-EC and PC-HP assays showed excellent agreement (k = 0.89, 95% CI 0.82-0.97). 
Stellenbosch University  https://scholar.sun.ac.za
33 
 
Moreover, the Bovigam PPD and modified PPD assays showed near-perfect agreement (k = 
0.99, 95% CI 0.96-1.00) with a single Bovigam PPD-positive animal testing modified PPD-
negative. The lowest agreement in test results was between the PC-EC assay and the SICTT (k 
= 0.69, 95% CI 0.63-0.85, Table 1). 
Of 63 buffaloes which tested positive on any test, 35/63 (55.6 %) were confirmed to be M. 
bovis infected and 41/63 (65%) were either confirmed to be M. bovis-infected or to have bTB-
like lesions with a score of 2 or more.  
4.2. Test performance 
The relative sensitivities of each assay and of selected assay combinations, for both the 
stringent and lenient criteria of infection, are summarized in Table 2. The Bovigam PPD and 
modified PPD assay showed the greatest individual test sensitivity, respectively. However, 
combinations of one or more IGRAs together with the SICTT showed the greatest overall 
diagnostic sensitivity (Table 2). Notably, 5/35 (14.3%) buffaloes confirmed to be M. bovis-
infected, tested negative for the SICTT but positive for one or more IGRAs.  
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a Single intradermal comparative tuberculin test. 
b Bovigam® assay utilizing M. bovis purified protein derivatives (PPD) and M. avium PPD. 
c Modified Bovigam® assay utilizing M. bovis, M. avium and M.  fortuitum PPDs. 
d Bovigam® assay utilizing peptides derived from ESAT-6 and CFP-10. 
e Bovigam® assay utilizing peptides derived from ESAT-6, CFP-10, Rv3615 and 3 additional mycobacterial antigens. 
 
Table 1      
The kappa (k) and 95% confidence interval values of agreement between five tests for bovine tuberculosis in African buffaloes (n = 283).  
  SICTTa Bovigam PPDb modified PPDc PC-ECd PC-HPe 
SICTT 1 0.77 (0.67 to 0.87) 0.78 (0.68 to 0.88) 0.69 (0.57 to 0.81) 0.74 (0.63 to 0.85) 
Bovigam PPD 0.77 (0.67 to 0.87) 1 0.99 (0.96 to 1.00) 0.73 (0.62 to 0.84) 0.81 (0.71 to 0.90) 
modified PPD 0.78 (0.68 to 0.88) 0.99 (0.96 to 1.00) 1 0.74 (0.63 to 0.85) 0.82 (0.73 to 0.91) 
PC-EC 0.69 (0.57 to 0.81) 0.73 (0.62 to 0.84) 0.74 (0.63 to 0.85) 1 0.89 (0.82 to 0.97) 
PC-HP 0.74 (0.63 to 0.85) 0.81 (0.71 to 0.90) 0.82 (0.73 to 0.91) 0.89 (0.82 to 0.97) 1 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
35 
 
a Single intradermal comparative tuberculin test. 
b Bovigam® assay utilizing M. bovis purified protein derivatives (PPD) and M. avium PPD. 
c Statistically different (p<0.05) compared to the PC-EC assay within that respective M. bovis isolated group.  
d Modified Bovigam® assay utilizing M. bovis, M. avium and M. fortuitum PPDs. 
e Bovigam® assay utilizing peptides derived from ESAT-6 and CFP-10. 
f Bovigam® assay utilizing peptides derived from ESAT-6, CFP-10, Rv3615 and 3 additional mycobacterial 
antigens. 
g Statistically different (p<0.05) compared to the SICTT within that respective M. bovis isolated group. 
  
Table 2 
The total number of positive animals, relative sensitivity (%) and 95% confidence interval for each test and 
possible test combinations calculated as the proportion of positive animals in a cohort where 1) either M. 
bovis was isolated or there were several small lesion foci to multifocal or confluent lesions (n = 41) and 2) 
only M. bovis was isolated (n = 35). 
 M. bovis and/or visible lesions M. bovis isolated 
Test and test combinations n = 41 
Sensitivity (%) 
(95%CI) n = 35 
Sensitivity (%) 
(95%CI) 
SICTTa 34/41 83 (0.71 to 0.95) 30/35 86 (0.74 to 0.97) 
Bovigam PPDb 38/41 93 (0.85 to 1.00)*c 32/35 91 (0.82 to 1.00) 
modified PPDd 37/41 90 (0.82 to 0.99) 32/35 91 (0.82 to 1.00) 
PC-ECe 31/41 76 (0.63 to 0.89) 28/35 80 (0.67 to 0.93) 
PC-HPf 34/41 83 (0.71 to 0.95) 30/35 86 (0.74 to 0.97) 
modified PPD & Bovigam PPD 38/41 93 (0.85 to 1.00)* 32/35 91 (0.82 to 1.00) 
modified PPD & PC-EC 38/41 93 (0.85 to 1.00)* 33/35 94 (0.87 to 1.00) 
modified PPD & PC-HP 38/41 93 (0.85 to 1.00)* 33/35 94 (0.87 to 1.00) 
modified PPD & SICTT 39/41 95 (0.89 to 1.00)* 34/35 97 (0.92 to 1.00) 
Bovigam PPD & PC-EC 39/41 95 (0.89 to 1.00)* 33/35 94 (0.87 to 1.00) 
Bovigam PPD & PC-HP 39/41 95 (0.89 to 1.00)* 33/35 94 (0.87 to 1.00) 
Bovigam PPD & SICTT 40/41 98 (0.93 to 1.00)*#g 34/35 97 (0.92 to 1.00) 
PC-EC & PC-HP 34/41 83 (0.71 to 0.95) 30/35 86 (0.74 to 0.97) 
PC-EC & SICTT 39/41 95 (0.89 to 1.00)* 35/35 100 (1.00 to 1.00)* 
PC-HP & SICTT 39/41 95 (0.89 to 1.00)* 35/35 100 (1.00 to 1.00)* 




As individual tests, the Bovigam PPD assay and modified PPD assay detected the greatest 
number of culture-confirmed M. bovis-infected buffaloes as well as buffaloes classified as M. 
bovis-infected based on culture or pathological criteria. However, the estimated diagnostic 
sensitivities of the PPD assays were not shown to be significantly greater than those of the 
SICTT or PC-HP assay. In contrast, the sensitivity of the PC-EC assay was significantly lower 
than that of the Bovigam PPD assay for the detection of animals with bTB-like lesions or 
confirmed M. bovis infection.  
When tests were used in combination, the SICTT together with either the PC-EC or PC-HP 
assays detected the greatest number of culture-confirmed M. bovis-infected animals. 
Respectively, these combinations were significantly more sensitive than either the PC-EC or 
PC-HP assays alone. Similarly, the SICTT and Bovigam PPD assay together detected the 
greatest number of animals that were classified as M. bovis-infected based on both culture or 
the presence of VL. Moreover, this test combination was significantly more sensitive than the 
use of the SICTT alone.  
Our finding that the Bovigam PPD assay shows greater sensitivity than the SICTT for the 
diagnosis of M. bovis infection in buffaloes is generally held to be true for cattle too (de la Rua-
Domenech et al., 2006; Schiller et al., 2010; Vordermeier et al., 2006). However, comparing 
the diagnostic sensitivities of these assays for cattle is problematic given the large variation in 
reported test conditions (de la Rua-Domenech et al., 2006) and because direct comparisons of 
the two tests in the same study have rarely been made (Vordermeier et al., 2006). A 
retrospective study in Ireland compared these tests in 767 M. bovis-infected cattle and 
estimated the IGRA to have a sensitivity of 88% while that of the SICTT was estimated to be 
60% and 74%, for standard and severe test interpretations, respectively (Gormley et al., 2006). 
Similarly, in two smaller studies, the sensitivities of the IGRA and intradermal test were 
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estimated to be 85% and 80% (González Llamazares et al., 1999), and 95% and 90% (Ameni 
et al., 2000), respectively. The wide range in reported sensitivities is indicative of the bias 
introduced by local study conditions (de la Rua-Domenech et al., 2006; Schmidt and Factor, 
2013) and highlights the benefit of evaluating comparative values in a single study, as done 
here. Nonetheless, a limitation of the present study is the likelihood that the sensitivities of the 
various assays were overestimated, as truly infected animals which tested negative on all tests 
were not included in the study. 
Importantly, while most infected buffaloes were both SICTT- and IGRA-positive, the 
agreement between these tests was only moderate and using them in combination detected a 
greater number of infected animals. In cattle, numerous studies have shown the occurrence of 
distinct subsets of infected individuals that only test positive with one or the other of these tests 
(Neill et al., 1994; Schiller et al., 2010; Vordermeier et al., 2006). For this reason, a greater 
number of M. bovis-infected cattle are detected when they are used in combination (Ameni et 
al., 2000; González Llamazares et al., 1999; Gormley et al., 2006). The parallel use of the 
SICTT and Bovigam PPD assay has therefore been advocated for testing of infected cattle 
herds (Gormley et al., 2006; Vordermeier et al., 2006) and the present study supports this 
approach for buffaloes.  
While the Bovigam PPD assay detected the greatest number of M. bovis-infected animals, 
limitations in the specificity of this assay have been reported for both buffaloes (A. L. Michel 
et al., 2011) and cattle (Schiller et al., 2010). When greater test specificity is desired, additional 
or alternative IGRA test antigens have been advocated for both species (Goosen et al., 2014; 
A. L. Michel et al., 2011; P J Cockle, 2006). Such approaches have commonly been associated 
with decreased test sensitivity (Schiller et al., 2010). However, in the present study, the 
modified PPD assay, which utilizes M. fortuitum PPD as an additional antigen, showed no 
significant difference in sensitivity compared to the Bovigam PPD assay. Moreover, these 
Stellenbosch University  https://scholar.sun.ac.za
38 
 
assays showed extremely high agreement and detected an equal number of animals confirmed 
to be M. bovis infected, supporting the use of this method for improving diagnostic specificity. 
In contrast, the PC-HP assay detected fewer such animals, in agreement with the 
manufacturer’s guidelines for cattle (Anonymous, n.d.). Moreover, the PC-EC assay detected 
still fewer and was significantly less sensitive than the Bovigam PPD assay. Again, these 
findings are in agreement with the manufacturer’s guidelines, findings from published studies 
in cattle (Schiller et al., 2010) and previous studies in buffaloes (Goosen et al., 2014; van der 
Heijden et al., 2016). 
In conclusion, the Bovigam PPD and modified PPD assays displayed greatest sensitivity for 
the detection of M. bovis-infected buffaloes. Nonetheless, the SICTT detected additional 
IGRA-negative animals and maximum sensitivity was attained when these assays were used in 
combination. The SICTT, however, is logistically challenging in buffaloes, given that animals 
must be chemically immobilized on two occasions. For this reason, further strategies for 
improving the diagnostic performance of IGRAs should be investigated in future work. 
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We evaluated commercially available bovine enzyme linked immunosorbent assays (ELISA) 
and a human IP-10 ELISA to measure IP-10, MIG, MCP-1, MCP-2, MCP-3 and IL1-RA in 
buffalo plasma in order to identify sensitive markers of the immune response to M. bovis-
specific peptides. Additionally, we found that all coding mRNA sequences of these cytokines 
showed very high homology with their homologues in domestic cattle (97% - 99%) as did the 
derived amino acid sequences (97% - 99%). This high sequence homology between cattle and 
buffaloes supports the use of bovine ELISAs for the detection these cytokines in buffaloes. 
MCP-1 concentration showed a positive correlation with that of IFN-γ (p = 0.0077) and appears 
to occur in far greater abundance in buffaloes when compared to humans. Using a bovine IP-
10 ELISA, levels of this cytokine were found to be significantly increased in antigen-stimulated 
blood samples from M. bovis test positive buffaloes (p < 0.0001) and IP-10 was detected in far 
greater abundance than IFN-γ. Measurement of IP-10 with this ELISA may prove to be a 
sensitive marker of M. bovis infection in African buffaloes.  
Keywords:  
African buffalo, Bovine tuberculosis, Enzyme linked immunosorbent assay, Interferon gamma-
induced protein 10, Interferon gamma 
Introduction 
In Africa, buffaloes (Syncerus caffer) are one of the most important maintenance hosts of a 
variety of pathogens which cause disease in domestic cattle (Michel and Bengis, 2012). These 
include indigenous diseases such as foot-and-mouth disease, Corridor disease and alien 
diseases such as bovine brucellosis and bovine tuberculosis (BTB) (Michel and Bengis, 2012). 
In order to better control such diseases, the development of improved tests for their diagnosis 
and an understanding of their pathogenesis and epidemiology is essential.  
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In the case of BTB, the immunological diagnosis of infection relies primarily on the detection 
of a cell mediated immune response to Mycobacterium bovis antigens (Vordermeier et al., 
2000). Examples of such assays include the single intradermal tuberculin skin test (SICTT) and 
the in vitro interferon gamma release assays (IGRA), the latter of which quantify antigen-
stimulated release of this cytokine. Recently, the specificity of IGRAs have been improved 
with the availability of the Bovigam PC-EC assay (BEC) utilizing peptides simulating the M. 
bovis proteins 6 kDa early secretory antigenic target (ESAT-6) and the 10 kDa culture filtrate 
protein (CFP-10) and the Bovigam PC-HP assay (BHP) utilizing ESAT-6, CFP-10, peptides 
simulating Rv3615 and 3 additional mycobacterial antigens (Bass et al., 2013; Goosen et al., 
2014). However, the sensitivity of BTB diagnosis in bovids remains suboptimal (Vordermeier 
et al., 2000) and it is possible that the quantification of biomarkers other than IFN-γ may 
improve the sensitivity of tests such as the BEC and BHP assays (Waters et al., 2003; 
Vordermeier et al., 2009; Jones et al., 2010; Blanco et al., 2011). 
In humans, candidate biomarkers for the diagnosis of Mycobacterium tuberculosis infection 
include monocyte-derived chemokine IFN-γ-induced protein 10 (IP-10) (Ruhwald et al., 
2009), monokine induced by interferon gamma (MIG) (Abramo et al., 2006; Chakera et al., 
2011), monocyte chemoattractant protein (MCP)-1, MCP-2, MCP–3 and interleukin 1 receptor 
antagonist (IL1-RA) (Ruhwald et al., 2009; Chakera et al., 2011). Ruhwald et al., (2009) 
reported significantly higher concentrations of IP-10, IL1–RA, MCP-1, MCP-2 and MCP-3 
compared to IFN-γ in antigen-stimulated blood samples from patients with active tuberculosis 
suggesting that all 5 biomarkers hold promise as immunological markers of tuberculosis in 
humans, with IP-10 and MCP-2 showing the greatest potential. Similarly, Abramo et al., (2005) 
showed a correlation between MIG concentration and IFN-γ production in 29 BCG-vaccinated 
controls and 24 TB patients, identifying MIG as a novel biomarker for M. tuberculosis 
infection. In cattle, Aranday-Cortes et al., (2012) reported IP-10, MIG, Granzyme A and IL-
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22 mRNA expression to show their promise as biomarkers of antigen-induced immune 
responses which might be utilized for the diagnosis of M. bovis infection. However, using a 
human IP-10 ELISA, a study in cattle which were experimentally infected with M. bovis 
concluded that IP-10 is a poor diagnostic biomarker for the detection of this infection in this 
species (Waters et al., 2012). 
The aim of this study was to evaluate the use of commercially available bovine ELISAs as well 
as a human IP-10 ELISA (Waters et al., 2012) for the measurement of selected candidate 
biomarkers of immune activation in response to M. bovis antigens in whole blood from African 
buffaloes. 
Material and methods 
Animals and sample preparation 
In 2012, randomly selected buffaloes in the Hluhluwe-iMfolozi Park were captured and tested 
for M. bovis infection using the SICTT as previously described (Parsons et al., 2011). After 
SICTT assessment, whole blood (WB) was collected from all SICTT-positive buffaloes into 
sodium heparin tubes by jugular venipuncture. Immediately after collection, one ml of WB 
from each animal was transferred to a QFT TB Antigen tube (containing peptides simulating 
ESAT-6, CFP-10 and TB7.7) and a QFT Nil tube (containing saline), respectively. The QFT 
tubes were shaken vigorously, and within 4 h of WB transfer to the QFT tubes, these were 
incubated at 37°C for 20 h, centrifuged at 3000 × g for 6 min and the plasma fraction stored at 
-80°C. To identify positive QFT reactors, plasma samples harvested from the QFT tubes were 
used in a modified QFT (mQFT) assay using a commercially available bovine IFN-γ ELISA 
(Table 1) and a cut-off of 66 pg/ml, as previously described (Parsons et al., 2011). As 
previously reported, the mQFT assay is a highly specific test of M. bovis infection (Parsons et 
al., 2011, 2012; Goosen et al., 2014) and buffaloes that tested positive on both the SICTT and 
mQFT assays were considered to be infected for the purposes of this study. 
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Sequencing of selected buffalo cytokine mRNAs 
Cytokine mRNA sequences of domestic cattle and sheep were obtained for IP-10, MIG, MCP-
1, MCP-2, MCP-3 and IL1-RA from the Ensemble Genome Browser 
(http://www.ensembl.org/index.html). These mRNA sequences were aligned using ClustalW2 
software (http://www.ebi.ac.uk/Tools/msa/clustalo/) and highly homologous regions were 
used to generate primers with Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/). Two forward and two reverse primers were designed, one of each within the 
untranslated regions flanking the translated region and one of each within the latter sequence 
(Table 2). Eight hundred ng of mRNA which had previously been extracted from M. bovis 
antigen-stimulated whole blood of two M. bovis-infected buffaloes (Parsons et al., 2012) was 
reverse transcribed using the QuantiTect Reverse Transcription (RT) Kit (Qiagen, Venlo, 
Netherlands) in a final volume of 80 µl. For each cytokine, each of the 4 primer combinations 
(0.4 µM of each primer) were used in a 25 µl PCR reaction containing 1 µl of cDNA , 2.5 µl 
of 10 x buffer and 0.1 µl of HotStarTaq DNA polymerase (reagents from Qiagen) and 0.4 mM 
dNTPs (Promega Corporation, Fitchburg, WI, USA). The PCR reactions were initiated by 
incubation at 95 °C for 15 min and consisted of 45 cycles of 94 °C for 1 min, 56 °C for 1 min 
and 72 °C for 1 min after which PCR products were incubated for a further 10 min at 72 °C. 
These amplification products were sequenced with the 3130xl Genetic Analyzer (Applied 
Biosystems, Foster City, CA, USA) according to the manufacturer’s guidelines. Cytokine 
protein sequences were then inferred from cDNA sequences using the EMBOSS Transeq 
software (http://www.ebi.ac.uk/Tools/st/emboss_transeq/). The degree of homology between 
all buffalo sequences and homologous sequences of cattle were calculated using ClustalW2 
software. 
  




The concentration of IP-10, MIG, MCP-1, MCP-2, MCP-3 and IL1-RA in the QFT-processed 
plasma samples was measured using commercially available ELISAs (Table 1) according to 
the manufacturer’s instructions. Furthermore, the absolute concentration of IP-10 in these 
samples was calculated with reference to a dilution series of recombinant human and bovine 
IP-10 for the human and bovine ELISAs, respectively (Table 1). 
Table 1  
Enzyme linked immunosorbent assay kits and components, and buffalo plasma dilutions, used to measure 
selected cytokines in QFT-processed whole blood from African buffaloes. 
Statistical analysis 
For each animal, the concentration of each analyte was characterised as the ELISA optical 
density (OD) and the antigen-dependent secretion of each analyte (ODTB-Nil) was defined as the 
OD value of the QFT TB Antigen plasma sample (ODTB) minus that of the QFT Nil plasma 
sample (ODNil). Using these OD values, a Wilcoxon signed-rank test was used to determine if 
the median concentration of each analyte was significantly different in plasma from the QFT 
Nil and TB Antigen tubes. Furthermore, absolute concentrations of antigen-specific IFN-γ and 
IP-10 were also compared using a Wilcoxon signed-rank test. The correlation between the 
Analyte Plasma dilution a Manufacturer Product information 
Bovine IFN-γ 1:2 Mabtech AB, Nacka Strand, Sweden Kit no. 3115-1H-20 






Bovine MIG 1:2 Bethyl Laboratories Inc., Texas, USA Kit no. E11-803 
Bovine MCP-1 1:1000 Bethyl Laboratories Inc. Kit no. E11-800 
Bovine MCP-3 1:10 MyBioSource, California, USA Kit no. MBS739771 
Bovine MCP-2 1:10 MyBioSource Kit no. MBS913274 
Bovine IL1-RA 1:2 MyBioSource Kit no. MBS740784 
Human IP-10 (HIP-10) 1:2 PeproTech®, Rocky Hill, NJ Kit no. 900-K39 
a Final plasma assay dilution in each well. 
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ODTB value for each analyte and that of IFN-γ was calculated as Spearman’s correlation 
coefficient.  
Results and Discussion 
The coding mRNA sequences of IP-10, MIG, MCP-1, MCP-2, MCP-3 and IL1-RA were 
obtained for two African buffaloes and submitted to the NCBI sequence database 
(http://www.ncbi.nlm.nih.gov/genbank/) (Table 2). The availability of these sequences should 
prove useful for the investigation of buffalo immunology by means of gene expression assays 
as previously described (Parsons et al., 2012). The sequences showed very high homology with 
those of cattle (97% - 99%) as did the inferred amino acid sequences (97%-99%) (Table 2). 
This degree of homology between buffalo and cattle suggests that commercial bovine ELISA 
kits could be used to quantify these proteins in plasma samples from buffaloes. 
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Table 2  
Sequencing data of selected cytokine mRNAs of the African buffalo: primers used for sequencing, NCBI Genbank accession numbers and homology 





Primer sequence (5’ – 3’) NCBI 
accession 
number: 









































































KM111561 98% 99% 
a External primers annealing in the untranslated regions, flanking the translated region of interest. 
b Internal primers annealing within the translated region of interest. 
 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
50 
 
These cytokines have been shown to be useful diagnostic biomarkers of cell activation 
following antigen recognition in humans (Abramo et al., 2006; Ruhwald et al., 2007, 2009). 
However, using commercial bovine ELISAs, only IFN-γ and IP-10 levels were found to be 
significantly increased in antigen-stimulated blood samples from SICTT-/mQFT-positive 
buffaloes (Figs. 1 and 2). Furthermore, MCP-1 was the only cytokine to show a significant  
 
Fig. 1  Optical densities (including median and interquartile range) obtained in ELISAs of 
plasma samples harvested from QFT Nil tubes (○) and QFT TB Antigen tubes (●) following 
overnight whole blood incubation at 37 °C for (a) IFN-γ, IP-10, and MIG, and (b) IL1-RA, 
MCP-1, MCP-2  and MCP-3 (n=18 SICTT-positive/mQFT-positive African buffaloes; * p < 
0.0001). 
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correlation with IFN-γ (p = 0.0077). The results for the remaining analytes were unexpected 
and we conclude that these are either poor indicators of antigen stimulation in buffaloes under 
the conditions described or that the bovine ELISAs did not efficiently detect these buffalo 
proteins. The latter is unexpected given the high degree of homology observed between cattle 
and buffalo transcripts of these analytes (Table 2). However, we cannot rule out that 
transcriptional, translational and post-translational differences between cattle and buffaloes 
may alter protein epitopes. Particularly surprising were the results for the human IP-10 ELISA 
which detected negligible levels of IP-10 in all buffalo plasma samples (0 – 137 pg/ml; Fig. 1). 
This is in contrast to findings from a study which used the same ELISA reagents to detect high 
levels of IP-10 in plasma from cattle following experimental infection with M. bovis (Waters 
et al., 2012). Our findings may indicate that the anti-human IP-10 antibodies used in this study 
have poor cross-reactivity to this protein of buffaloes despite their high predicted homology 
with cattle IP-10 (Table 2).  
Fig. 2 The difference in plasma levels of IFN-γ, IP-10, MIG, IL1-RA, MCP-1, MCP-2 and 
MCP-3 harvested from QFT TB antigen tubes and QFT Nil tubes following overnight whole 
blood incubation at 37 ºC (n=18 SICTT-positive/mQFT-positive African buffaloes). 
Stellenbosch University  https://scholar.sun.ac.za
52 
 
For the MCP-1 ELISA, plasma samples were diluted 1:1000. Nonetheless, MCP-1 ELISA 
signals were highly correlated with IFN-γ (p = 0.0077) suggesting that the results are a true 
reflection of MCP-1 abundance. Absolute concentrations of MCP-1 were not calculated; 
however, in humans, a typical plasma dilution factor for such an assay is 1:8 (Ruhwald et al., 
2009) and our findings suggest that MCP-1 is particularly abundant in antigen-stimulated 
buffalo plasma. This cytokine is associated with a Th2 bias and enhanced production of IL-4 
(Deshmane et al., 2009), both of which are associated with greater BTB pathology in cattle 
(Thacker et al., 2007). Moreover, an increase in MCP-1 plasma concentration due to a 
polymorphism in the MCP-1 gene promoter region has been shown to be associated with an 
increased susceptibility to pulmonary tuberculosis in humans (Flores-Villanueva et al., 2005). 
Our findings, therefore, warrant further investigation of the role of MCP-1 in buffalo BTB.  
Using the bovine IP-10 ELISA, levels of this cytokine were shown to be elevated in antigen-
stimulated samples in all SICTT-positive/mQFT-positive buffaloes (Figs. 1 and 2). In addition, 
antigen-specific IP-10 was released in significantly greater abundance than IFN-γ (p<0.0001). 
This suggests that IP-10 may be at least as sensitive as IFN-γ as a diagnostic biomarker in 
buffaloes. Furthermore, because of its abundance, it may prove to be a more sensitive marker 
of M. bovis infection as has been shown for M. tuberculosis infection in humans (Ruhwald et 
al., 2007, 2009, 2011). The IP-10 molecule is also highly stable at room temperature (Aabye 
et al., 2011) and human plasma samples dried on filter membrane paper and transported via 
conventional postal service showed no loss of IP-10 signal (Aabye et al., 2013). This could 
prove particularly useful for the transport of buffalo samples from remote locations. Moreover, 
human studies have also shown M. tuberculosis-specific IP-10 responses to be less affected by 
co-infection with other bacteria and viruses, including HIV (Kabeer et al., 2010; Ruhwald et 
al., 2011). Again, this attribute might be particularly useful in buffaloes, a species which is 
known to be infected with a number of livestock pathogens (Michel and Bengis, 2012). 
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In conclusion, we have shown that IP-10 is a useful marker of immune activation by M. bovis 
antigens when using the bovine IP-10 ELISA. Our results highlight the limitations imposed on 
veterinary research by the lack of optimal immunological reagents and the need to interpret 
experimental results in this light. Our findings also suggest that the diagnostic potential of IP-
10 for BTB in cattle be re-evaluated using species-specific reagents. Studies are currently under 
way to compare the sensitivity of IP-10 and IFN-γ as diagnostic biomarkers of M. bovis 
infection in African buffaloes. 
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African buffaloes (Syncerus caffer) are maintenance hosts of Mycobacterium bovis, the 
causative agent of bovine tuberculosis. They act as reservoirs of this infection for a wide range 
of wildlife and domestic species and the detection of infected animals is important to control 
the geographic spread and transmission of the disease. Interferon-gamma (IFN-γ) release 
assays utilizing pathogen-derived peptide antigens are highly specific tests of M. bovis 
infection; however, the diagnostic sensitivities of these assays are suboptimal. We evaluated 
the diagnostic utility of measuring antigen-dependent interferon gamma-induced protein 10 
(IP-10) release as an alternative to measuring IFN-γ. M. bovis-exposed buffaloes were tested 
using the Bovigam PC-EC and Bovigam PC-HP assays and a modified QuantiFERON TB-
Gold (mQFT) assay. IP-10 was measured in the harvested plasma and was produced in 
significantly greater abundance in response to M. bovis antigens in Bovigam-positive than in 
Bovigam-negative animals. For each assay, using the Bovigam results as a reference, receiver 
operating characteristic curve analysis was done to determine diagnostically relevant cut off 
values for IP-10. Hereafter, mQFT test results derived from measurement of IP-10 and IFN-γ 
were compared and a larger number of Bovigam-positive animals were detected using IP-10 
as a diagnostic marker. Moreover, using IP-10, agreement between the mQFT assay and the 
Bovigam assays was increased while the excellent agreement between the Bovigam assays was 
retained. We conclude that IP-10 is a sensitive marker of antigen recognition and that 
measurement of this cytokine in antigen-stimulated whole blood might increase the sensitivity 
of conventional IGRAs in African buffaloes. 
Keywords: African buffalo, bovine tuberculosis, enzyme linked immunosorbent assay, 
interferon gamma-induced protein 10, gamma interferon  




Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB) in a wide range of 
domestic animals and wildlife (1). BTB in cattle populations is intensively controlled in many 
countries as it can result in reduced productivity or death of infected animals and poses a serious 
zoonotic risk. In South Africa, the African buffalo (Syncerus caffer) is a maintenance host of 
M. bovis and the early detection of infected animals is important to control the transmission of 
the pathogen to other wildlife and domestic species and to prevent the geographic spread of 
this disease by translocation (2, 3).  
The most sensitive method for diagnosing M. bovis infection is by detection of the host’s cell 
mediated immune response to pathogen-specific antigens (4). Examples of such tests are the in 
vivo tuberculin skin test (TST) and in vitro interferon gamma release assays (IGRAs). The latter 
detect the release of interferon gamma (IFN-γ) in whole blood or from isolated peripheral blood 
mononuclear cells (PBMCs) in response to M. bovis purified protein derivative (PPD) (5) or 
more specific antigens such as the 6 kDa early secreted antigenic target (ESAT-6) and the 10 
kDa culture filtrate protein (CFP-10) (6, 7). Recently, IGRAs utilizing the latter antigens have 
been described and evaluated for the diagnosis of BTB in buffaloes, i.e. the modified 
QuantiFERON TB-Gold  (mQFT) assay and the commercially available Bovigam PC-EC 
assay (PC-EC) and Bovigam PC-HP assay (PC-HP)(3, 8). Notably, the mQFT assay, which is 
highly practical for use under field conditions, and the highly specific PC-EC assay are both 
less sensitive than the less specific PC-HP IGRA (8). As such, the utility of the mQFT and PC-
EC assays would be increased by improving the detection of immune sensitization to ESAT-
6/CFP-10.  
One possibility for this might be the detection of additional or alternative biomarkers other than 
IFN-γ. In humans, a number of immunological proteins have been investigated as potential 
markers of immune activation in response to antigenic peptides and IFN-γ-induced protein 10 
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(IP-10) has proven to be a very strong candidate for the diagnosis of infection with M. 
tuberculosis (9–11). Similarly, and in contrast to reports from cattle studies (5), in M. bovis-
infected buffaloes, IP-10 is significantly elevated in whole blood stimulated with ESAT-
6/CFP-10 and is produced in much greater abundance than IFN-γ, suggesting its potential as 
an alternative or ancillary biomarker to IFN-γ in this species (10). 
The aim of this pilot-study was, therefore, to determine if the measurement of IP-10 in antigen-
stimulated whole blood is a useful diagnostic marker in buffaloes and whether it could be used 
to increase the sensitivity of established IGRAs. Because the PC-EC and PC-HP assays have 
been shown to have a greater sensitivity than the TST in this species (8) and because human 
studies have solely investigated IP-10 responses to peptide antigens (11), we used the PC-EC 
and PC-HP assays as reference tests. Moreover, since mycobacterial culture is considered to 
be an imperfect gold standard of M. bovis infection (12) and because this data was not available 
for Bovigam-negative animals in this study, an optimal diagnostic cut off value for IP-10 could 
not be calculated. We therefore evaluated the diagnostic utility of IP-10 by calculating a 
diagnostically relevant cut off value for this cytokine and thereafter, using both IFN-γ and IP-
10 as diagnostic markers, the agreement between the mQFT assay and the highly sensitive and 
specific Bovigam peptide assays. 
Materials and methods 
Animals 
In 2013, two hundred and thirty-one buffaloes were captured during an annual BTB test-and-
slaughter program in the Hluhluwe-iMfolozi Game Reserve (South Africa) as previously 
described (3). Of these, eighty-four buffaloes were randomly selected and following chemical 
immobilization as previously described (8), ten ml of heparinized whole blood was collected 
from each animal by jugular venipuncture. Ethical approval for the capture and testing of these 
animals was granted by the Stellenbosch University Animal Care and Use Committee. 
Stellenbosch University  https://scholar.sun.ac.za
62 
 
mQFT, PC-EC and PC-HP assays 
One ml of blood was transferred to a QFT Nil tube, containing saline, and a QFT TB Antigen 
tube, containing peptides simulating ESAT-6, CFP-10, and TB 7.7 (Qiagen, Venlo, Limburg, 
Netherlands), respectively. Tubes were mixed thoroughly and incubated for 20h at 37ºC. After 
incubation, 150 μl of plasma was collected without centrifugation from each QFT tube. The 
concentration of IFN-γ in all plasma samples was measured using a bovine enzyme-linked 
immunosorbent assay (ELISA) according to the manufacturer’s recommendations (kit 3115-
1H-20; Mabtech, AB, Nacka Strand, Sweden). For each animal, the IFN-γ concentration in the 
Nil tube was subtracted from that in the TB Antigen tube and a differential value greater than 
66 pg/ml was defined as a positive mQFT test result, as previously determined (3). 
Performance of the PC-EC and PC-HP assays (Prionics, Schlieren-Zurich, Switzerland) 
included the incubation of 250 μl of whole blood with 25 μl saline, a 25 μl solution of peptides 
simulating ESAT-6 and CFP-10 (PC-EC assay) and a 25 μl solution of these peptides together 
with peptides simulating Rv3615 and 3 additional M. bovis antigens (PC-HP assay), 
respectively, for 20h at 37 ºC.  All further analyses were done according to the manufacturer’s 
instructions. 
Bovine IP-10 ELISA and IP-10 assays 
The concentration of IP-10 in all plasma samples was measured as follows: 100 µl of a 5 μg/ml 
solution of anti-bovine IP-10 capture antibody (Kingfisher Biotech Inc., St Paul, USA, Catalog 
number PB0385B-100) in phosphate buffered saline (PBS) was added to each well of a 96-
well flat bottom polystyrene plate (NUNC, Roskilde, Denmark) and incubated overnight at 4 
ºC. Thereafter, and after each subsequent step, plates were washed with a wash buffer 
consisting of 0.05% Tween-20 (Sigma-Aldrich, St. Louis, USA) in PBS. Blocking buffer (200 
µl), consisting of 0.1% bovine serum albumin (BSA) (Roche, Basel, Switzerland) and 0.05% 
Tween-20 in PBS, was added to each well and the plates were incubated for 1h at room 
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temperature (RT). Then, aliquots of 25 µl of plasma in 75 µl blocking buffer as well as a 
dilution series (0 – 5000 pg/ml) of recombinant bovine IP-10 protein (Kingfisher, Catalog 
Number RP0079B-005) were incubated in duplicate wells for 2h at RT. Hereafter, the plates 
were incubated at RT for 1h with 100 µl/well of 0.01 µg/ml biotinylated anti-bovine IP-10 
antibody (Kingfisher, Catalog Number PBB0393B-050) diluted in blocking buffer and 
subsequently at RT for 1h with 100 µl/well of a streptavidin-horse radish peroxidase solution 
(R&D Systems, Minneapolis, USA) diluted in blocking buffer. After a final wash, plates were 
incubated for 30 min at RT with 100 µl of 0.4 mg/ml o-phenylenediamine dihydrochloride/well 
(Sigma-Aldrich, St. Louis, USA). Optical densities of each of the wells was measured at 450 
nm with a LT-4000 Microplate Reader (Labtech, Vienna, Austria) and the concentration of IP-
10 in each well was calculated using the standard curve generated from the dilution series of 
recombinant bovine IP-10 protein.  
For each diagnostic assay, the IP-10 test result was calculated as the IP-10 concentration in the 
antigen-stimulated sample minus the IP-10 concentration in the sample incubated with sterile 
PBS. IP-10 tests using plasma obtained from the mQFT assay, PC-EC assay and PC-HP assay 
were defined as the IP-10(QFT), IP-10(EC) and IP-10(HP) tests, respectively. 
Statistical analysis 
Animals which tested positive by either the PC-EC or PC-HP assay were defined as Bovigam-
positive while animals which tested negative for both assays were defined as Bovigam-
negative. IP-10(QFT), IP-10(EC) and IP-10(HP) test results for animals which were Bovigam-
positive and Bovigam-negative were compared using the Wilcoxon signed-rank test. For each 
IP-10 test, an optimal diagnostic cut off value for discrimination between Bovigam-positive 
and Bovigam-negative animals was calculated using receiver operating characteristic (ROC) 
curve analysis. The relevant cut off value for each assay was determined by selecting the 
maximum value of Youden’s index (YI), i.e. sensitivity + specificity – 1, which corresponds 
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to the point nearest the upper left corner on the ROC curve (13). These cut off values were used 
to define animals as IP-10 test-positive or -negative. The diagnostic performance of each IP-
10 assay was calculated as the area under the curve (AUC) of the respective ROC curve. All 
analyses were done using GraphPad Prism version 5 (GraphPad Software, March 2007). Lastly, 
using GraphPad software (http://graphpad.com/quickcalcs/kappa1/), agreement between 
selected assays was calculated as Cohen’s kappa coefficient (k). 
Results 
IGRA test results 
 
Of 84 buffaloes tested, the mQFT, PC-EC and PC-HP assays identified 31 (37%), 40 (48%) 
and 42 (50%) test-positive animals based on IFN-γ values, respectively. Forty-four animals 
were defined as Bovigam-positive, and of these, the mQFT, PC-EC and PC-HP assays detected 
71%, 91% and 95%, respectively (Table 1). 
Table 1 
The number and percentage of Bovigam-positive animals (n = 44) detected by measuring M. 
bovis-specific IFN-γ and IP-10 following the processing of whole blood with the mQFT, PC-
EC and PC-HP assays. 
  
 No (%) of positive cases 
Assay IFN-γ IP-10 
mQFT 31 (71) 38 (86) 
PC-EC 40 (91) 36 (82) 
PC-HP 42 (95) 41 (93) 
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Antigen-induced IP-10 release in whole blood 
In order to confirm IP-10 as a useful biomarker of antigen-dependent immune activation, the 
IP-10 test results for Bovigam-positive and -negative buffaloes were compared using the 
Wilcoxon signed-rank test. For Bovigam-positive and –negative animals, the median IP-
10(QFT), IP-10(EC) and IP-10(HP) test results were 5458 pg/ml and 5 pg/ml, 10269 pg/ml and 
671 pg/ml, and 6773 pg/ml and 734 pg/ml, respectively (Fig. 1). For all assays, the IP-10 test 
results were significantly greater for Bovigam-positive than -negative animals (p < 0.001; Fig. 
1).  
 
Fig. 1 IP-10 test results (M. bovis-specific IP-10 release) for Bovigam-positive and Bovigam-
negative buffaloes following processing of whole blood with the (a) mQFT, (b) PC-EC and (c) 
PC-HP assays showing median and interquartile ranges. IP-10 release was significantly greater 
in Bovigam-positive animals. * p < 0.001. 
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IP-10 as a diagnostic biomarker 
Diagnostic cut off values for the IP-10(QFT), IP-10(EC) and IP-10(HP) tests were calculated 
by comparing IP-10 test results for Bovigam-positive and -negative buffaloes using ROC curve 
analysis (Fig. 2, Table 2). A cut off value of 1486 pg/ml for the IP-10(QFT) assay detected all 
mQFT-positive animals and an additional 10 responders of which 7 were Bovigam-positive. A 
cut off value of 2155 pg/ml for the IP-10(HP) assay detected 40/42 (95%) PC-HP-positive 
animals and an additional 5 animals of which 2 were IP-10(EC) positive and 1 which was PC-
EC-positive. The IP-10(QFT), IP-10(EC) and IP-10(HP) tests detected 86%, 82% and 93% of 
the 44 Bovigam-positive animals (Table 1). Of the Bovigam-negative buffaloes, 32/40 (80%) 
tested negative for all IP-10 assays (Table S1 under Appendix II). 
Figure 2 Receiver operating characteristic curves indicating the performance of selected cut 
off values in order to differentiate between Bovigam-positive and Bovigam-negative buffaloes 
by measurement of IP-10 in plasma obtained following processing of whole blood with (a) the 
mQFT, (b) the PC-EC and (c) the PC-HP assays. The high agreement between the Bovigam 
and IP-10 assays is indicated by the large area under the curve (AUC). 
 




Receiver operating characteristic curve analysis of the IP-10(QFT), IP-10(EC) and IP-10(HP) 








a CI, confidence interval; AUC, area under the curve.. 
 
In order to further characterise the diagnostic utility of IP-10, agreements between the IGRAs 
and IP-10 tests were determined using Cohen’s kappa coefficient. The agreement between the 
mQFT assay and the combined Bovigam assays (k = 0.69) was substantially lower than the 
agreement between these assays and the IP-10(QFT) test (k = 0.79) (Table 3). Furthermore, the 
excellent agreement between the PC-EC and PC-HP assays was retained when IP-10 was used 




% sensitivity  
(95% CI) 
% specificity  
(95% CI) AUC 
mQFT 1486 86.4 (72.7-94.8) 92.5 (79.6-98.4) 0.93 
PC-EC 4557 81.8 (67.3-91.8) 92.5 (79.6-98.4) 0.93 
PC-HP 2155 93.2 (81.4-98.6 90 (76.4-97.2) 0.93 
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Table 3 Agreement between the mQFT, PC-EC, and PC-HP assays and the IP-10(QFT), IP-10(EC), and IP-10(HP) tests in a cohort of Bovigam-





a ND, not done. 
 
  
Assay Bovigam PC-HP IP-10(HP) PC-EC IP-10(EC) 
mQFT 0.69 (0.55 to 0.84) 0.74 (0.60 to 0.88) ND 0.69 (0.53 to 0.84) ND 
IP-10(QFT) 0.79 (0.65 to 0.92) 0.79 (0.65 to 0.92) 0.76 (0.63 to 0.90) 0.74 (0.59 to 0.88) 0.71 (0.56 to 0.86) 
PC-HP ND 1 0.83 (0.72 to 0.95) 0.86 (0.75 to 0.97) 0.79 (0.65 to 0.92) 
IP-10(HP) ND 0.83 (0.72 to 0.95) 1 0.79 (0.66 to 0.92) 0.81 (0.69 to 0.93) 
PC-EC ND 0.86 (0.75 to 0.97) 0.79 (0.66 to 0.92) 1 0.83 (0.71 to 0.95) 
IP-10(EC) ND 0.79 (0.65 to 0.92) 0.81 (0.69 to 0.93) 0.83 (0.71 to 0.95) 1 
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The most sensitive immunological tests of M. bovis infection measure cell-mediated immune 
responses to pathogen-specific antigens, i.e. delayed type hypersensitivity in the case of the 
TST and IFN-γ release in the case of IGRAs. The latter tests depend on the presence of 
circulating antigen-specific memory T lymphocytes; however, if these cells are present in low 
numbers, IFN-γ production may be below the threshold of detection. Nonetheless, IFN-γ 
concentrations as low as 10 pg/ml as well as other cytokines such as TNF-α, Interleukin (IL)-
12 and IL-4 can induce activation of monocytes and neutrophils resulting in secretion of IP-10 
by these cells (14–16). IP-10 can therefore be used as a proxy for lymphocyte activation (9). 
In humans, IP-10 has been shown to be a sensitive diagnostic biomarker of antigen recognition 
in a whole blood system (17) and the present study indicates its diagnostic utility in buffaloes. 
Firstly, IP-10 is produced in far greater amounts in whole blood in response to M. bovis antigen 
stimulation in Bovigam-positive buffaloes than in Bovigam-negative animals (Fig 1 and 2). In 
addition to confirming this cytokine as a sensitive biomarker of antigen-induced immune 
activation as previously reported in buffaloes (10), these findings indicate the diagnostic 
potential of this protein to distinguish between these animal groups. Similarly, in humans, IP-
10 is strongly induced in whole blood from tuberculosis patients stimulated with M. 
tuberculosis-specific antigens (11).  
Secondly, the diagnostic performance of IP-10 was demonstrated by ROC analysis and the 
calculation of relevant diagnostic cut off values for the IP-10 tests. These analyses returned 
AUC values greater than 0.92 for all IP-10 tests indicating the discriminatory power of this 
biomarker (Table 1). This finding is particularly noteworthy given the limitations of these 
analyses which were performed with results from a restricted number of animals. A more 
accurate calculation of diagnostic cut off values would require many hundreds of animals in 
both the test-positive and test-negative groups (18). Also, for the purposes of our analyses we 
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elected to use the purely objective measure of a relevant cut off value, i.e. the YI index. This 
method, however, does not account for the fact that, when compared to the reference assays, 
the IP-10 tests might reasonably be expected to correctly identify a greater number of truly 
infected animals. It is probable, therefore, that this approach would overestimate the 
appropriate cut off values and underestimate the apparent sensitivities of the IP-10 tests. The 
limitation of this analysis is suggested by the relatively high cut off value of 4557 pg/ml 
calculated in this way for the IP-10(EC) test. This value is significantly higher than that 
calculated for the IP-10(QFT) assay and consequently, the IP-10(EC) assay detected only 82% 
of Bovigam-positive animals. Conversely, the IP-10(QFT) test cut off value of 1486 pg/ml 
increased the detection of Bovigam-positive animals from 71% for the mQFT assay to 86% 
indicating the diagnostic utility of this biomarker. 
Thirdly, agreement between the IP-10(QFT) test and the combination of Bovigam assays (k = 
0.79) was substantially greater than that between the latter result and the mQFT assay (k = 
0.69). To a large degree, this increase in agreement is as a result of the increased sensitivity of 
the IP-10(QFT) test (Table 1). However, in addition to being a measure of agreement between 
positive tests, the kappa statistic measures agreement between negative test results and as such, 
the increased k-value in this case is also highly suggestive that an optimal IP-10 cut off value 
might not significantly compromise diagnostic specificity.  Moreover, the diagnostic value of 
IP-10 is further indicated given that the excellent agreement between the PC-EC and PC-HP 
assays (k = 0.86) is retained when using IP-10 as a biomarker (k = 0.81). 
A number of limitations of this pilot-study preclude definitive conclusions on the diagnostic 
utility of IP-10 in buffaloes. As mentioned, the limited sample size may have influenced the 
calculation of appropriate IP-10 test cut off values. Moreover, the utility of IP-10 was evaluated 
using antigen-specific whole blood incubation assays which have been optimized for the 
measurement of IFN-γ and alternative incubation periods might be more appropriate for the 
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measurement of IP-10. Also, Bovigam-negative animals which tested positive with the IP-10 
tests were not slaughtered and no further immunological investigation was possible to confirm 
these results.  
In conclusion, while recent advancements have been made in increasing the specificity of tests 
of CMI for the diagnosis of M. bovis infection in African buffaloes (3, 8) there remains a need 
for increased diagnostic sensitivity. This pilot-study indicates that IP-10 shows promise as a 
diagnostic biomarker in this species and that its measurement in peptide-stimulated whole 
blood may increase the sensitivity of conventional IGRAs. Future investigations of the 
diagnostic utility of this protein should include the validation of optimal diagnostic cut off 
values, the determination of its diagnostic sensitivity and specificity and an investigation of the 
diagnostic performance of IP-10 in combination with IFN-γ. 
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The measurement of interferon gamma-induced protein 10 (IP-10) in antigen-stimulated whole 
blood is a sensitive biomarker of Mycobacterium bovis infection in African buffaloes (Syncerus 
caffer). However, this species often occurs in remote locations and diagnostic samples must be 
transported to centralized laboratories for processing. In humans, plasma IP-10 is highly stable 
and this feature contributes to its diagnostic utility; for this reason we aimed to characterize the 
stability of this molecule in buffaloes. Blood from M. bovis-infected and -uninfected animals 
was incubated with pathogen-specific peptides, saline and phytohaemagglutinin, respectively. 
Plasma fractions were harvested and aliquots of selected samples were: i) stored at different 
temperatures for various times; ii) heat treated before storage at RT, and iii) stored on Protein 
Saver Cards (PSCs) at RT for either 2 or 8 weeks before measurement of IP-10. Incubation of 
plasma at 65 °C for 20 min caused no loss of IP-10 and this protein could be quantified in 
plasma stored on PSCs for 2 and 8 weeks. Moreover, for all storage conditions, IP-10 retained 
its excellent diagnostic characteristics. These features of IP-10 might allow for the heat 
inactivation of potentially infectious plasma which would facilitate the safe and simple 
transport of samples. 
Keywords: African buffalo, diagnosis, interferon gamma-induced protein 10; Mycobacterium 
bovis, Protein Saver Cards 
Introduction 
Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB), a zoonosis which 
can cause reduced productivity and death in a wide range of animals (Michel et al., 2006). In 
South Africa, African buffaloes (Syncerus caffer) are a major reservoir host of this pathogen 
and can act as a source of infection for cattle (Musoke et al., 2015) and other wildlife species 
(Olivier et al., 2015). The disease is therefore intensively controlled in buffaloes and this 
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requires the immunodiagnosis of infected animals, primarily by the detection of cell-mediated 
immunity to M. bovis antigens (Vordermeier et al., 2000). 
One such test is the interferon gamma (IFN-γ) release assay (IGRA) which detects the secretion 
of this cytokine by memory lymphocytes in response to M. bovis purified protein derivative 
(PPD) or antigens such as the 6-kDa early secreted antigenic target (ESAT-6) and the 10-kDa 
culture filtrate protein (CFP-10) (Vordermeier et al., 2001; Waters et al., 2012). However, the 
applicability of this assay within the context of wildlife is confounded by the need for plasma 
cytokine concentrations to be measured with specialised equipment at centralised laboratories, 
while animals are often located in remote environments. This requires the transport of plasma 
under appropriately cooled or frozen conditions (Duncombe et al., 2013). Moreover, the 
movement of wildlife specimens risks the spread of highly infectious pathogens such as Foot 
and Mouth and African swine fever viruses (Duncombe et al., 2013). 
As an alternative to IFN-γ, measurement of the antigen-specific release of IFN-γ-induced 
protein 10 (IP-10) has proven to be a strong diagnostic candidate in humans (Chakera et al., 
2011; Ruhwald et al., 2007). Similarly, in buffaloes, the release of IP-10 in antigen-stimulated 
whole blood has been shown to be a useful marker of M. bovis infection (Goosen et al., 2014a) 
and to have a diagnostic sensitivity which is greater than conventional IGRAs (Goosen et al., 
2015). In humans, plasma IP-10 is highly stable at 23 ºC for up to 2 weeks (Aabye et al., 2012) 
and dried plasma, stored at 37 ºC for 4 weeks on filter membrane Protein Saver Cards (PSCs) 
showed no decrease in IP-10 concentration (Aabye et al., 2012). This characteristic of IP-10 
could have particular utility for veterinary samples as plasma stored on PSCs might easily be 
transported without any loss of diagnostic accuracy. 
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The aim of this study was, therefore, to investigate the diagnostic performance of assays 
measuring antigen-specific IP-10 for the diagnosis of M. bovis in African buffaloes following 
storage of plasma under various conditions.  
Materials and methods 
Animals 
African buffaloes with known M. bovis exposure were captured, as previously described 
(Goosen et al., 2014b), in 2013 (Herds A13 and B13) and 2015 during a BTB test-and-slaughter 
program in the Hluhluwe-iMfolozi Game Reserve, South Africa. Buffaloes were tested using 
the TST, as previously described (Goosen et al., 2014b; Parsons et al., 2011), as well as the 
mQFT assay, as described below. Animals were classified as either BTB-positive (TST and 
mQFT-positive) or BTB-negative (TST and mQFT-negative) and assigned to two groups. 
Group 1 consisted of all BTB-positive buffaloes (n = 15) and 19 randomly selected BTB-
negative animals tested in 2015. Group 2 consisted of all BTB-positive buffaloes (n = 17) and 
20 randomly selected BTB-negative animals from Herd B13. Ethical approval for the capture 
and testing of these buffaloes was granted by the Stellenbosch University Animal Care and Use 
Committee. 
Whole blood stimulation 
Ten ml of heparinized whole blood was collected, by venepuncture of the jugular vein, from 
each animal. One ml of blood was incubated for 20 h at 37 ºC in each of the following QFT 
blood collection tubes (Qiagen, Venlo, Limburg, Netherlands): a Nil tube containing saline and 
a TB Antigen tube containing ESAT-6, CFP-10 and TB7.7 peptides. Additionally, 1 ml of 
blood was incubated with phytohaemagglutinin (PHA) (Sigma-Aldrich, St. Louis, Missouri, 
USA) at a final concentration of 10 μg/ml. Thereafter, tubes were centrifuged at 1500 x g for 
6 min and plasma was harvested from each tube and stored at -80 ºC. Plasma IFN-γ 
concentrations were determined using a bovine IFN-γ enzyme linked immunosorbent assay 
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(ELISA) according to the manufacturer’s instructions (kit 3115-1H-20; Mabtech, AB, Nacka 
Strand, Sweden). The mQFT assay result was defined as the IFN-γ concentration in plasma 
from the Nil tube subtracted from that from the TB Antigen tube. Animals with an assay result 
greater than 66 pg/ml were defined as mQFT-positive, as previously described (Parsons et al., 
2011). 
Heat treatment of plasma 
Plasma derived from PHA-stimulated blood (activated plasma) and blood co-incubated with 
saline (non-activated plasma) was obtained from 8 randomly selected animals. Activated 
plasma was pooled, as was non-activated plasma, and aliquots of each pool were stored at -80 
ºC, 4 ºC, room temperature (RT) and 37 ºC for 0, 4, 8 and 12 days. Additionally, pooled 
activated plasma was incubated at 65 °C for 20 min and aliquots of  heat-treated as well as 
untreated samples were stored at RT for 0, 1, 2, 3, 4, 7 and 14 days. For animals from Group 
1, QFT-processed plasma was treated as follows: one aliquot of 30 μl was incubated at 65 ºC 
for 20 min while a second aliquot was stored at -80 ºC. 
Storage of plasma on PSC 
For animals from Group 2: 25 µl aliquots of QFT-processed plasma were spotted, in duplicate, 
onto 903 Protein SaverTM Cards (Whatmann plc, Maidstone, UK), dried at RT for 4 h, and 
stored at RT for 2 weeks (PSC-2w) and 8 weeks (PSC-8w), respectively. The remaining plasma 
was stored at -80 °C. Additionally, 5 aliquots of activated plasma (as described above) were 
spotted onto PSCs, as were 5 aliquots which had first been incubated at 65 ºC for 20 min, and 
these were stored at RT for 7 days. All plasma samples spotted onto PSCs were stored in sealed 
plastic bags with a desiccant. 
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Measurement of IP-10 by ELISA 
The concentration of IP-10 in plasma samples was measured using a commercial bovine IP-10 
ELISA (Kingfisher Biotech Inc., St. Paul, MN, USA), as previously described in detail (Goosen 
et al., 2015), and recorded as either the relative concentration (ELISA optical density, OD) or 
as the absolute concentration of IP-10 (pg/ml). For plasma spotted onto PSCs, absolute amounts 
of IP-10 (pg) in samples was measured using this ELISA with the following modification: the 
sample comprised two circular discs punched out from the centre of the spot using a standard 
office paper punch (Carl Mfg. Illinois, USA, Inc.) and incubated in 100 µl of blocking buffer.  
Statistical analysis 
For plasma samples, diagnostic IP-10 test results were defined as the plasma concentration of 
IP-10 in blood incubated in the QFT TB Antigen tube minus that incubated in the Nil tube. 
Similarly, for the PSC-2w and PSC-8w samples, test results were defined as the difference in 
absolute amounts of IP-10 in the sample derived from the TB Antigen and Nil tubes. Using 
receiver operating characteristic (ROC) curve analysis, an optimal diagnostic cut off value for 
plasma samples stored at -80 ºC was calculated by comparing test results for all BTB-positive 
(n = 32) and all BTB-negative buffaloes (n = 39). For BTB-positive and -negative animals from 
Group 2, cut off values were independently calculated for the PSC-2w and PSC-8w samples, 
respectively. In all cases, these values were calculated as the maximum value of Youden’s 
index (Youden, 1950) and the diagnostic performance of each test was calculated as the area 
under the curve (AUC). 
For BTB-positive animals from Group 1, the correlation between IP-10 test results derived 
from untreated and heat-treated plasma was described using Pearson’s correlation coefficient 
and test results were compared using Student’s t-test for paired samples. For BTB-positive 
buffaloes from Group 2, the correlations between the test results for the plasma IP-10, the PSC-
2w and the PSC-8w assays were similarly calculated. Furthermore, PSC-2w and PSC-8w assay 
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results for these animals were compared using student’s t-test as was the mean concentration 
of IP-10 in activated plasma stored on PSCs, either with or without heat treatment. 
 The agreement between selected diagnostic results were calculated as Cohen’s kappa 
coefficient (k) using freely available online software (http://graphpad.com/quickcalcs/kappa1/) 
and all other analysis was done using GraphPad Prism version 5 software (GraphPad Software, 
Inc., La Jolla, CA, USA). 
Results and Discussion 
Determination of a diagnostic cut off value for plasma IP-10 
 
An optimal diagnostic cut off value of 1420 pg/ml (Fig. 1) for the plasma IP-10 assay resulted 
in a test sensitivity of 94 % (95% CI: 79.2-99.2) and test specificity of 92% (95% CI: 79.1-
98.4). This corresponds closely with an optimal IP-10 cut off value for QFT-processed samples 
from buffaloes which has previously been calculated as 1486 pg/ml (Goosen et al., 2015). 
  
  




Fig. 1. Heat treatment of plasma does not compromise the detection of antigen-induced IP-10 
release. Whole blood from BTB-positive and -negative buffaloes was incubated in 
QuantiFERON blood collection tubes and test results were calculated as the M. bovis peptide-
specific release of IP-10 in plasma. For plasma stored at−80◦C, results for each group were 
compared and an optimal assay cut-off value of1420 pg/ml was determined by ROC analysis. 
For BTB-positive animals, IP-10 assay results obtained using plasma treated at 65◦C for 20 




Thermal stability of plasma IP-10 
The relative concentration of IP-10 in non-activated plasma, measured as the ELISA optical 
density, was similar in samples stored at -80 ºC, 4 ºC, RT and 37 ºC for 12 days, indicating the 
thermal stability of this protein (Table 1). These findings are similar to those from a human 
study which showed plasma IP-10 to be stable for up to 14 days at RT (Aabye et al., 2013). 
However, for activated plasma from buffaloes, while the concentration of IP-10 remained 
stable for 12 days at -80 °C, it was markedly decreased with an increase in storage temperature 
(Table 1). More importantly, IP-10 was undetected in activated plasma stored at either RT or 
37 °C for 4, 8 and 12 days (Table 1). We postulate that this temperature-dependant loss of IP-
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10 in PHA-stimulated plasma may be indicative of enzymatic degradation of this protein as 
chemokines are commonly subjected to post-translational proteolysis (Wolf et al., 2008). This 
hypothesis is supported by the fact that activated leukocytes produce several kinds of proteases, 
including CD26 (dipeptidylpeptidase IV) and numerous matrix metalloproteases (MMPs), 
many of which degrade chemokines (Lee et al., 2001; Moser et al., 2004). 
Table 1         
The concentration of IP-10 in samples of pooled plasma from 8 buffaloes, stored 
at different temperatures for between 0 and 12 days.    
  Plasma IP-10 concentration (optical density)    
Plasma Storage Day 0 Day 4 Day 8 Day 12    
Non-activateda -80 ºC 0.31 0,28 0,34 0,28    
4 ºC n.d.
b 0,29 0,34 0,28    
RTc n.d. 0,27 0,31 0,28    
37 ºC n.d. 0,25 0,27 0,26    
Activatedd -80 ºC 0.46 0,44 0,53 0,43    
4 ºC n.d. 0,44 0,37 0,15    
RT n.d. 0,08 0,08 0,09    
37 ºC n.d. 0,08 0,08 0,09    
a Collected and pooled following overnight incubation of whole blood with saline.   
b Not done.         
c Room temperature.        
d Collected and pooled following overnight incubation of whole blood with 
phytohaemagglutinin (10 µg/ml). 
 
Heat treatment of activated plasma at 65 °C for 20 min abrogated the rapid drop in IP-10 
concentration in activated plasma stored at RT (Table 2) further suggesting that this 
phenomenon is mediated by a proteolytic enzyme which is susceptible to thermal denaturation. 
Importantly, this treatment resulted in a marginal loss of IP-10 and confirmed the thermal 
stability of this chemokine (Table 2). 
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Table 2        
The concentration of IP-10 in samples of pooled plasma from 8 buffaloes, harvested 
following incubation of whole blood with phytohaemagglutinin, and either heated at 
65 °C for 20 min or maintained at -80 °C before storage at room temperature for 
between 0 and 14 days. 
 Plasma IP-10 concentration (optical density) 
Treatment Day 0 Day 1 Day 2 Day 3 Day 4 Day 7 Day 14 
-80 °C 0,43 0,44 0,13 0,02 0,01 0,01 0,00 
65 °C for 20 min 0,38 0,40 0,40 0,39 0,37 0,31 0,29 
 
Similarly, for BTB-positive animals, IP-10 assay results obtained using plasma treated at 65 
°C for 20 min were modestly but significantly lower than those obtained using untreated plasma 
(Fig 1); however, these results were highly correlated (P < 0.0001). Notably, using the cut off 
of 1420 pg/ml, as calculated above, diagnostic IP-10 assay results obtained using untreated 
plasma and plasma treated at 65 °C for 20 min showed extremely high agreement (k =  0.94, 
95% CI: 0.82 to 1.00). 
Stability of IP-10 on PSCs 
The optimal diagnostic cut off value for the PSC-2w assay was 1328 pg, which resulted in a 
test sensitivity of 88% (95% CI: 64% - 99%) and a test specificity of 95 % (95% CI: 75% - 
100%) (Fig 2). A cut off value of 589 pg for the PSC-8w assay resulted in a test sensitivity of 
83% (95% CI: 56.6-96.2) and test specificity of 95% (95% CI: 75.1-100) (Fig 2). For both 
assays, ROC analysis returned AUC values of approximately 0.97, indicating their excellent 
diagnostic performance. Plasma IP-10 test results for BTB-positive animals from Group 2 were 
significantly correlated with those of the PSC-2w assay (p < 0.0005) and PSC-8w assay (p < 
0.0001), demonstrating the stability of buffalo plasma IP-10 stored on PSCs. These findings 
agree with results from a human study which also showed a highly significant correlation 
between IP-10 detected in plasma and after storage on PSCs (Aabye et al., 2013, 2012). 
However, the magnitude of the PSC-8w assay results were significantly lower than those of the 
PSC-2w assay (p < 0.001), indicating a gradual loss of IP-10 stored on the PSCs at RT (Fig 2). 
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In contrast, human IP-10 has been shown to be highly stable on PSCs stored at RT over a period 
of 4 weeks (Aabye et al., 2013). However, the stability of this protein stored in this manner 
was not evaluated over a longer period and human plasma stored on PSCs at temperatures of 
37 °C and 50 °C showed a loss of IP-10 over time which was similar to that seen in the present 
study (Aabye et al., 2012). This phenomenon did not preclude interpretation of the PSC-2w 
and PSC-8w assays; however, it was associated with a slight loss in assay sensitivity over time 
(Fig 2). Nonetheless, the plasma IP-10 assay showed very good agreement with both the PSC-
2w and PSC-8w assays, respectively (k = 0.84, 95% CI: 0.67 to 1.00 and k = 0.79, 95% CI: 
0.59 to 0.98). There was no significant difference between the mean IP-10 concentration from 
heat treated plasma samples (5368 pg/ml) and untreated plasma samples (5118 pg/ml) blotted 
on PSCs and left at RT for 1 week (p = 0.2829). 
Fig. 2. The sensitivity of the IP-10 assay is decreased after storage of plasma on Protein Saver 
Cards (PSCs). Whole blood from BTB-positive and -negative buffaloes was incubated in 
QuantiFERON blood collection tubes and test results were calculated as the M. bovis peptide-
specific release of IP-10 in plasma. Results for BTB-positive animals derived using plasma 
stored on PSCs for 2 weeks at room temperature (PSC-2wassay) were significantly greater than 
those using plasma stored for 8 weeks (PSC-8w assay). Optimal cut-off values of 1328 pg and 
589 pg, and assay sensitivities of 88% and 83%, respectively, were calculated by ROC analysis. 
*, p < 0.01, Student’s t-test. 
 




The diagnostic cut off value calculated for the IP-10 plasma assay in this study is comparable 
with that previously reported for buffaloes (Goosen et al., 2015), indicating that this cytokine 
is a robust biomarker of M. bovis infection in this species. As for humans, buffalo IP-10 can be 
measured in plasma stored on PSCs. However, the diagnostic sensitivity of tests utilizing such 
samples is reduced with increased storage time and this technique might best be used for short 
term storage of plasma, i.e. during transport. Particularly noteworthy is the thermal stability of 
plasma IP-10 and samples can be heated at 65 °C for 20 min with no degradation of this protein. 
This characteristic of IP-10 might allow for heat-inactivation of plasma pathogens and for the 
safe transport of diagnostic samples. 
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Chapter 7 – General Conclusion 
African buffaloes (Syncerus caffer) are one of the most important wildlife maintenance hosts 
of bTB on the African continent. Spill-over of this pathogen to other wildlife species or 
domestic cattle may not only result in reduced productivity or death of infected animals, but 
also poses a serious zoonotic risk (1). Current control strategies in South Africa strive to 
effectively manage and prevent the spread of bTB by controlling it in livestock and buffaloes, 
using a test and slaughter program. However, diagnostic assays used during these programs, 
such as the SICTT and commercially available IGRAs, are still believed to be sub-optimal for 
the diagnosis of bTB in bovids (2). A potential approach to improving detection of M. bovis 
infection could be the use of novel diagnostic antigens or the identification of alternative or 
ancillary biomarkers to IFN-γ (3–6). Therefore, the studies presented in this dissertation aimed 
to identify and develop novel approaches for improving the detection of M. bovis infection in 
African buffaloes.  
Assays of cell mediated immunity 
The modified QuantiFERON TB-Gold assay (mQFT), a human TB test, has been previously 
described for the diagnosis of bTB in buffaloes (7). Additional investigation has shown that 
plasma collected from the QFT tubes prior to centrifugation could be reliably utilized to detect 
interferon-gamma from buffalo whole blood (8). Moreover, increasing the blood incubation 
time from 20h to 30h improved the mQFT assay’s sensitivity. However, in this study, both the 
Bovigam® PC-EC assay and the Bovigam® PC-HP assay were more sensitive than either the 
SICTT or mQFT assay in its current format. Nonetheless, the application of the mQFT assay 
remains practical for bTB diagnosis in buffaloes under field conditions compared to any 
Bovigam assay and improvements, as described above, may improve its sensitivity.  
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In an additional study, both the Bovigam PPD assay and modified Bovigam PPD assay 
displayed greatest sensitivity for the detection of M. bovis-infected buffaloes (Goosen, 
unpublished data). The SICTT detected additional IGRA-negative animals and maximum 
sensitivity was attained when the SCITT and Bovigam PPD assays were used in combination. 
These findings are supported by previous cattle studies that advocate the parallel use of the 
SICTT and the Bovigam PPD assay (9,10).  Evidence-based diagnostic test algorithms will 
improve detection and inform policy decision in the bTB control programs for buffalo in South 
Africa.  
IP-10 as biomarker of cell-mediated immunity  
The studies presented here have also shown that 1) IP-10 is a useful marker of immune 
activation in buffaloes when using a commercially available IP-10 bovine ELISA (11); 2) 
measurement of antigen-specific IP-10 can accurately distinguish between uninfected and  M. 
bovis-infected buffaloes and addition of the IP-10 assay increases the sensitivity over 
conventional IGRAs (12); 3)  the calculated cut-off value for IP-10 was consistent in two 
independent studies, suggesting its reliability as a potential diagnostic assay in buffaloes 
(12,13); 4)  IP-10 can be measured in plasma stored on Protein Saver Cards (PSCs); however 
the sensitivity of tests utilizing such samples is reduced with increased storage (13); and lastly, 
5) plasma samples can be heated to 65 ºC for 20 min with no degradation of IP-10, 
demonstrating the thermal stability of this cytokine (13).  
These findings have highlighted the potential application of IP-10 for the diagnosis of bTB in 
African buffaloes. Improved sensitivity of M. bovis-specific IGRAs is a significant advantage 
of using IP-10 as a preferred biomarker in this species.  These results suggest that IP-10 may 
be a useful biomarker of immunological activation for detection of other diseases in buffalo. 
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Other advantages of IP-10 are its thermal tolerance and stability on PSCs. These characteristics 
facilitate movement of diagnostic samples by permitting heat-inactivation of potential 
pathogens in plasma, and transport of samples by conventional methods, respectively.  Storage, 
transport and biosafety are important issues when developing a diagnostic test for wildlife 
which live in remote areas, away from veterinary laboratories. Therefore, IP-10 as a diagnostic 
biomarker may facilitate testing of buffalo herds. 
Future studies 
To successfully advance this research, the performance of IGRAs, the SICTT and the bovine 
IP-10 ELISA must be further investigated in buffalo populations with varying bTB prevalence 
to determine factors influencing the performance of these diagnostic tests. Additional studies 
should be conducted to address the logistical constraints of cytokine release assays under field 
conditions by evaluating commercially prepared M. bovis-antigen tubes. Given the thermal and 
storage stability characteristics of IP-10, further research is needed to thoroughly evaluate its 
diagnostic performance in M. bovis-antigen stimulated plasma samples that are stored and 
transported under expected field conditions from buffaloes with variable stages of M. bovis 
infection and disease to determine whether these provide alternative methods to address current 
logistical limitations. Lastly, since IP-10 appears to be produced in significant abundance in 
antigen-stimulated buffalo whole blood, additional research should investigate the use of this 
biomarker for other diagnostic applications. 
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Appendix I  
Supplementary Table 1 
Test results for African buffaloes with discordant bovine tuberculosis test outcomes. 
Animal 
BEC a BHP b mQFT20 c mQFT30 d SICTT e M.bovis culture f 
Result ΔOD g (450nm) Result ΔOD (450nm) Result ΔIFN-γ h (pg/ml) Result ΔIFN-γ (pg/ml) 
1 + i 0.158 + 0.131 - j 16 - 57 - n.d. k 
2 + 2.839 + 2.564 + 841 + 1352 + - 
3 - 0.000 - 0.027 - 0 - 3 - n.d. 
4 - 0.051 - 0.055 - 0 - 3 - n.d. 
5 - 0.022 - 0.029 - 0 - 0 - n.d. 
6 - 0.005 - 0 - 13 - 55 - n.d. 
7 - 0.017 - 0 - 0 - 5 - n.d. 
8 - 0.050 + 0.170 - 0 - 17 - n.d. 
9 + 1.228 + 1.109 + 226 + 767 + - 
10 - 0 - 0 - 0 - 0 - n.d. 
11 - 0.001 - 0.023 - 0 - 0 - n.d. 
12 - 0.024 - 0.025 - 0 - 7 - n.d. 
13 - 0.054 - 0.068 - 23 - 14 - n.d. 
14 + 0.549 + 0.586 + 137 + 783 + M.bovis 
15 - 0.000 - 0.000 - 0 - 2 - n.d. 
16 + 2.717 + 3.654 + 837 + 1258 + M.bovis 
17 - 0.040 - 0 - 40 - 40 - n.d. 
18 + 2.530 + 2.414 + 435 + 1080 + - 
19 + 2.477 + 2.033 + 712 + 882 + M.bovis 
20 + 2.757 + 2.650 + 1293 + 1582 + M.bovis 
21 - 0.002 - 0.003 - 0 - 0 - n.d. 
22 - 0 - 0 - 0 - 0 - n.d. 
23 + 1.864 + 1.566 + 216 + 893 + M.bovis 
24 - 0.000 - 0.000 - 0 - 0 - n.d. 
25 - 0 - 0 - 3 - 0 - n.d. 
26 + 2.262 + 2.192 + 1192 + 846 + M.bovis 
27 - 0.043 - 0.057 - 0 - 19 - n.d. 
28 + 0.318 + 0.283 + 122 + 290 + M.bovis 
29 - 0 - 0 - 0 - 6 - n.d. 
30 - 0.042 - 0.091 - 46 - 35 + n.v.l. l 
31 - 0 - 0.062 - 0 - 0 - n.d. 
Stellenbosch University  https://scholar.sun.ac.za
Stellenbosch University  https://scholar.sun.ac.za
96 
 
32 + 0.150 + 0.206 - 0 - 0 - n.d. 
33 + 0.260 + 0.165 - 0 - 11 + n.d. 
34 + 0.095 + 0.098 - 0 - 20 - n.d. 
35 - 0.001 - 0 - 0 - 0 - n.d. 
36 + 0.168 + 0.191 - 46 + 236 + M.bovis 
37 + 2.777 + 2.599 + 367 + 915 + M.bovis 
38 - 0 - 0 - 0 - 5 - n.d. 
39 - 0.001 - 0.077 - 0 - 0 - n.d. 
40 - 0.005 - 0.025 - 0 - 0 - n.d. 
41 +  0.643 - 0.000 - 14 - 0 - n.d. 
42 + 0.253 + 0.184 - 36 + 74 + - 
43 + 0.254 + 0.226 - 26 + 108 + M.bovis 
44 + 2.080 + 2.159 + 397 + 1330 + M.bovis 
45 - 0 - 0 - 7 - 20 - n.d. 
46 - 0.000 - 0.000 - 0 - 0 - n.d. 
47 - 0.000 - 0.039 - 0 - 0 - n.d. 
48 - 0.065 - 0.057 - 44 - 3 + M.bovis 
49 + 0.111 - 0.083 - 12 - 27 + M.bovis 
50 + 0.393 + 0.410 - 1 - 2 - n.d. 
51 + 0.618 + 0.578 + 190 + 409 + n.d. 
52 - 0.085 - 0.073 - 45 - 41 + - 
53 + 0.816 + 0.919 + 177 + 383 + M.bovis 
54 + 1.817 + 1.854 + 444 + 934 + M.bovis 
65 + 2.462 + 2.433 + 734 + 875 + n.d. 
66 - 0.000 - 0.022 - 0 - 0 - n.d. 
67 + 0.191 + 0.212 - 22 - 162 - M.bovis 
68 - 0 + 0.288 + 191 + 549 + M.bovis 
69 - 0.023 - 0.024 - 17 - 0 - n.d. 
70 - 0.067 + 0.103 - 26 + 68 - n.d. 
71 + 3.019 + 2.741 + 1387 + 1347 + M.bovis 
72 - 0.005 - 0 - 0 - 34 - n.d. 
73 + 1.427 + 0.984 + 584 + 663 + M.bovis 
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a Bovigam® assay utilising the ESAT-6 and CFP-10 proteins          
b Bovigam® assay utilising a hypothetical protein            
c modified QuantiFERON® TB-Gold assay (20 h blood incubation) 
d modified QuantiFERON® TB-Gold assay (30 h blood incubation) 
e single intradermal comparative tuberculin test 
f All culture-positive samples was tested by Polymerase Chain Reaction to determine if  M.bovis. (Warren et al., 2006) 
g Optical density of the peptide stimulated sample minus that of the Nil sample. 
h IFN-γ concentration in the TB Antigen-stimulated sample minus that in the Nil sample  
I positive 
j negative 
k not done = n.d  
l no visible lesion = n.v.l. 
74 + 2.715 + 3.084 + 1001 + 72 + M.bovis 
75 - 0.088 + 0.154 + 129 + 142 - n.d. 
76 - 0 - 0 - 0 - 1 - n.d. 
77 + 0.179 + 0.295 + 120 + 99 + M.bovis 
78 + 0.841 + 0.843 + 280 + 503 + n.d. 
79 + 0.931 + 1.031 + 450 + 661 + M.bovis 
80 + 2.653 + 2.509 + 890 + 638 + M.bovis 
81 + 2.064 + 2.136 + 1036 + 528 + M.bovis 
82 + 0.286 + 0.258 + 137 + 218 + M.bovis 
83 - 0.000 - 0.019 - 34 - 60 - n.d. 
84 + 2.205 + 2.155 + 307 + 789 + M.bovis 
85 + 2.923 + 2.566 + 669 + 592 + M.bovis 
86 - 0.000 - 0.000 - 0 - 4 - n.d. 
87 + 2.134 + 2.047 + 1312 + 1180 + M.bovis 
88 - 0.000 - 0.000 - 0 - 4 - n.d. 
89 + 1.903 + 2.381 + 947 + 1303 + n.d. 
90 - 0.082 - 0.074 - 0 - 11 - n.d. 
91 - 0 - 0.043 - 22 - 15 - - 
92 - 0 - 0 - 0 - 7 - n.d. 
93 - 0.004 - 0.000 - 0 - 9 - n.d. 
94 - 0.075 - 0.075 - 36 + 121 - n.d. 
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Antigen-specific cytokine release and test results for the mQFT, PC-EC and PC-HP assays and the IP-10(QFT), IP-10(EC) and IP-10(HP) 
tests in a cohort of Bovigam-positive (n = 44) and Bovigam-negative (n = 40) buffaloes. 
Animal 














1 +b  0.158 + 0.131 -c  16 - 4250 + 2456 - 116 
2 + 2.839 + 2.564 + 841 + 10079 + 6688 + 3896 
3 - 0 - 0.027 - 0 - 503 - 1488 - 0 
4 - 0.051 - 0.055 - 0 - 217 - 114 - 0 
5 - 0.022 - 0.029 - 0 - 2890 - 1173 - 67 
6 - 0.005 - 0 - 13 - 0 - 0 - 129 
7 - 0.017 - 0 - 0 - 381 - 241 - 0 
8 - 0.05 + 0.17 - 0 - 0 - 0 - 58 
9 + 1.228 + 1.109 + 226 + 8242 + 7172 + 2123 
10 - 0 - 0 - 0 - 38 - 0 - 29 
11 - 0.001 - 0.023 - 0 - 0 - 0 - 8 
12 - 0.024 - 0.025 - 0 - 412 - 1023 - 0 
13 - 0.054 - 0.068 - 23 - 3924 + 3332 - 1122 
14 + 0.549 + 0.586 + 137 + 7871 + 3351 + 2458 
15 - 0 - 0 - 0 - 276 - 95 - 42 
16 + 2.717 + 3.654 + 837 + 14849 + 6536 + 6187 
17 - 0.04 - 0 - 40 - 2314 - 204 - 9 
18 + 2.53 + 2.414 + 435 + 11217 + 8101 + 4064 
19 + 2.477 + 2.033 + 712 + 9227 + 7746 + 3751 
20 + 2.757 + 2.65 + 1293 + 14469 + 8349 + 4100 
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21 - 0.002 - 0.003 - 0 - 1 - 226 - 0 
22 - 0 - 0 - 0 - 710 - 313 - 0 
23 + 1.864 + 1.566 + 216 + 17424 + 13790 + 8595 
24 - 0 - 0 - 0 - 121 - 0 - 0 
25 - 0 - 0 - 3 - 15 - 1194 - 0 
26 + 2.262 + 2.192 + 1192 + 17943 + 12492 + 6319 
27 - 0.043 - 0.057 - 0 + 6817 + 4484 - 1260 
28 + 0.318 + 0.283 + 122 + 14317 + 9372 + 7587 
29 - 0 - 0 - 0 - 0 - 0 - 0 
30 - 0.042 - 0.091 - 46 - 4467 - 738 + 2131 
31 - 0 - 0.062 - 0 - 453 - 87 - 49 
32 + 0.15 + 0.206 - 0 - 601 - 580 - 0 
33 + 0.26 + 0.165 - 0 + 4564 + 4503 + 3552 
34 + 0.095 + 0.098 - 0 + 4836 + 2487 - 506 
35 - 0.001 - 0 - 0 - 435 - 782 - 322 
36 + 0.168 + 0.191 - 46 + 4610 + 2540 + 3934 
37 + 2.777 + 2.599 + 367 + 25117 + 17035 + 9929 
38 - 0 - 0 - 0 - 690 - 1451 - 0 
39 - 0.001 - 0.077 - 0 + 5372 - 276 - 0 
40 - 0.005 - 0.025 - 0 - 350 - 449 - 0 
41 +  0.643 - 0 - 14 - 762 - 646 - 0 
42 + 0.253 + 0.184 - 36 + 13413 + 6777 + 5823 
43 + 0.254 + 0.226 - 26 + 11507 + 13281 + 6860 
44 + 2.08 + 2.159 + 397 + 24131 + 24131 + 12615 
45 - 0 - 0 - 7 - 1999 - 2141 - 467 
46 - 0 - 0 - 0 - 1121 - 1224 - 0 
47 - 0 - 0.039 - 0 - 0 - 244 - 0 
48 - 0.065 - 0.057 - 44 - 4551 + 3124 - 964 
49 + 0.111 - 0.083 - 12 - 4033 + 2544 + 1499 
50 + 0.393 + 0.41 - 1 + 7618 + 6247 - 544 
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51 + 0.618 + 0.578 + 190 + 13172 + 12676 + 5011 
52 - 0.085 - 0.073 - 45 + 5963 + 6069 - 1472 
53 + 0.816 + 0.919 + 177 + 12062 + 12043 + 11539 
54 + 1.817 + 1.854 + 444 + 21058 + 15605 + 9817 
65 + 2.462 + 2.433 + 734 + 6468 + 5509 + 5133 
66 - 0 - 0.022 - 0 - 1437 - 1979 - 0 
67 + 0.191 + 0.212 - 22 + 5498 + 3254 + 4365 
68 - 0 + 0.288 + 191 - 3277 + 2761 + 4447 
69 - 0.023 - 0.024 - 17 - 1233 - 435 - 0 
70 - 0.067 + 0.103 - 26 - 2585 + 2324 + 1533 
71 + 3.019 + 2.741 + 1387 + 6677 + 6292 + 7252 
72 - 0.005 - 0 - 0 - 315 - 491 - 0 
73 + 1.427 + 0.984 + 584 + 7937 + 5331 + 8345 
74 + 2.715 + 3.084 + 1001 + 11288 + 6986 + 11075 
75 - 0.088 + 0.154 + 129 - 1642 + 2168 + 1679 
76 - 0 - 0 - 0 - 0 - 0 - 0 
77 + 0.179 + 0.295 + 120 + 13721 + 14188 + 4793 
78 + 0.841 + 0.843 + 280 + 13375 + 5651 + 6849 
79 + 0.931 + 1.031 + 450 + 11557 + 9063 + 9956 
80 + 2.653 + 2.509 + 890 + 14559 + 11934 + 11511 
81 + 2.064 + 2.136 + 1036 + 9191 + 6769 + 9143 
82 + 0.286 + 0.258 + 137 + 7734 + 5972 + 5784 
83 - 0 - 0.019 - 34 - 1650 - 1753 + 1669 
84 + 2.205 + 2.155 + 307 + 14510 + 9983 + 10983 
85 + 2.923 + 2.566 + 669 + 22194 + 15026 + 7024 
86 - 0 - 0 - 0 - 298 - 61 - 162 
87 + 2.134 + 2.047 + 1312 + 10459 + 7201 + 11788 
88 - 0 - 0 - 0 - 1409 - 1034 - 393 
89 + 1.903 + 2.381 + 947 + 12951 + 9063 + 13874 
90 - 0.082 - 0.074 - 0 - 2397 - 730 - 1129 
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91 - 0 - 0.043 - 22 - 710 - 231 - 0 
92 - 0 - 0 - 0 - 651 - 1190 - 0 
93 - 0.004 - 0 - 0 - 1253 - 858 - 153 
94 - 0.075 - 0.075 - 36 - 3747 - 1839 + 3446 
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Table S1             
Test results for all African buffaloes positive for any test.                 
Animal Bovigam PPDa  modified PPDb PC-ECc PC-HPd SICTTe 
M. bovis 
isolationf PM examinationg 








OD(Nil)  Result 
OD(HP) - 
OD(Nil)        
A1 +
i 
1,625 1,562 + 0,119 + 1,143 + 1,310 + + 2
j-R; 1-Tr; 1-M; 2-To; 3-L 
A6 + 0,333 0,302 + 0,013 -
k 0,003 - 0,060 + + 3-R; 1-Tr 
A12 + 1,725 1,580 + 0,022 + 0,620 + 0,750 + + 2-R 
A14 - -0,053 0,071 - -0,206 + 0,108 + 0,606 - + 2-R 
A24 + 0,538 0,535 + 0,018 + 0,213 + 0,351 + + SUS-R 
A25 + 2,400 2,324 + 0,049 + 1,114 + 1,230 + + 3-R 
A35 - 0,082 0,065 - 0,020 - 0,028 - 0,032 + - 1-R 
A49 + 0,426 0,401 + 0,005 + 0,154 + 0,188 + + 3-R 
A51 - -0,003 0,202 - -0,129 - 0,060 + 0,174 - - 0 
A54 + 0,396 0,356 + 0,018 + 0,180 + 0,234 + + 0 
A59 - 0,028 0,024 - 0,006 - 0,030 - 0,024 + + 0 
A61 + 0,174 0,117 + 0,059 - 0,040 - 0,082 + + 3-Tr 
A62 + 0,245 0,234 + 0,016 + 0,113 + 0,107 + - 1-R; 1- Tr 
A66 + 0,436 0,421 + 0,013 + 0,142 + 0,197 + + 3-R; 3-To 
A78 + 0,767 0,762 + 0,007 + 0,474 + 0,586 + + 2-R; 1-To 
A82 + 0,976 0,901 + 0,022 + 0,513 + 0,649 + + 2-R 
A93 + 0,103 0,095 + 0,004 - 0,053 + 0,099 + + 2-R 
A99 + 0,988 0,932 + 0,013 + 0,454 + 0,568 + + 2-R 
A101 + 1,618 1,408 + 0,045 + 0,451 + 0,522 + + 3-R; 2-To 
A107 - 0,092 0,087 - 0,011 - 0,033 - 0,045 + + 2-R 
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B3 + 1,726 1,512 + 0,196 + 0,743 + 0,793 + + 2-To 
B5 - 0,043 0,047 - -0,017 + 0,361 - -0,023 + - 0 
B15 + 0,438 0,292 + 0,140 - -0,001 - 0,017 - - 0 
B16 + 0,332 0,309 + 0,016 + 0,192 + 0,212 - - 0 
B19 + 1,858 1,685 + 0,535 + 1,104 + 1,296 + + 2-P; 1-S 
B24 + 0,943 0,935 + 0,057 + 0,403 + 0,710 + - 0 
B26 + 1,676 1,621 + 0,035 + 0,981 + 0,959 + + 1-Tr; 2-L 
B28 + 0,197 0,125 + 0,050 - 0,007 - 0,011 - - 1-R; 1-Pa 
B29 + 2,269 2,132 + 0,055 + 0,972 + 0,790 + + 3-M; 3-L 
B30 + 1,888 1,794 + 0,024 + 0,890 + 0,919 + + 3-Tr; 3-M; 1-P; 3-L 
B31 + 0,268 0,275 + 0,023 - 0,066 + 0,095 + + 0 
B39 + 2,599 2,102 + 0,155 + 2,930 + 2,607 + + 3-R 
B40 + 0,159 0,113 - 0,159 - -0,060 - 0,019 - - 2-R; 1-Tr; 1-M 
B45 - 0,088 -1,027 - 0,071 + 0,689 - -0,008 - - 0 
B47 - 0,034 0,004 - 0,029 + 0,114 - 0,039 - - 0 
B49 - 0,228 0,077 - 0,071 - 0,063 - 0,083 + - 0 
B50 + 0,885 0,761 + 0,045 - 0,007 - 0,006 - - 0 
B51 - 0,053 0,005 - 0,005 + 0,137 - 0,008 - - 1-Tr; SUS-L 
B52 + 2,855 1,129 + 0,197 + 2,706 + 2,563 - + 2-L 
B53 + 0,456 0,424 + 0,121 + 0,297 + 0,294 + + 2-L 
B59 + 2,881 2,273 + 0,073 + 2,527 + 2,812 + - 2-Tr 
B63 + 2,029 0,833 + 2,181 - 0,036 + 0,142 + - 2-Pa 
B65 + 1,955 1,844 + 0,125 + 0,780 + 1,073 + - 1-R 
B66 + 3,433 3,008 + 0,077 + 2,616 + 2,594 - + 3-P; 3-L 
B67 + 1,134 1,089 + -0,048 + 0,661 + 0,842 + + 3-R; 3-Tr; 3-M;3-L 
B68 + 0,163 0,123 + 0,115 - -0,023 - -0,012 - - 0 
B69 - 0,261 0,084 - 0,031 - 0,008 - -0,008 + - 0 
B75 + 3,017 2,923 + 0,099 + 2,244 + 2,561 + - 2-L; 
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a Bovigam® assay utilizing M. bovis purified protein derivatives (PPD) and M. avium PPD. 
b Modified Bovigam® assay utilizing M. bovis, M. avium and M.  fortuitum PPDs. 
c Bovigam® assay utilizing peptides derived from ESAT-6 and CFP-10. 
d Bovigam® assay utilizing peptides derived from ESAT-6, CFP-10, Rv3615 and 3 additional mycobacterial antigens. 
e Single intradermal comparative tuberculin test. 
f Warren et al. (2006) 
g Post-mortem examination of the: Retropharyngeal lymph nodes (R), Tracheobronchial lymph nodes (Tr), Mediastinal or mediastinal lymph nodes (M), 
Tonsils (To), Lungs (L), Submandibular lymph nodes (S), Prescapular lymph nodes (P) and Parotid lymph nodes (Pa). 
h Optical density of the antigen stimulated sample minus that of the Nil sample. 
i Positive. 
j Lesion scores: 0-no visible lesions; 1-small focal lesion; 2-several small foci or single large lesion and 3-multifocal or confluent lesions. 
k Negative. 
l not done. 
B78 + 0,164 0,108 + 0,049 - 0,009 - 0,032 - - 2-retro 
B80 + 0,981 0,895 + 0,082 + 0,126 + 0,179 - + 3-retro 
B82 + 0,312 0,268 + 0,087 - 0,042 - 0,076 - - 0 
B89 + 0,170 0,133 + 0,048 - 0,046 - 0,056 + + 2-L 
B92 + 0,665 0,664 + -0,121 + 0,180 + 0,257 - + 2-R; 1-M; 3-L 
C18 + 1,190 1,043 + 0,123 + 0,370 + 0,497 + + 3-R 
C28 - 0,212 -0,153 - 0,606 + 0,108 + 0,118 - - 0 
C29 + 1,155 1,003 + 0,079 + 0,440 + 0,569 + - 1-R 
C47 + 2,901 2,488 + 0,148 + 2,675 + 2,755 + + 3-S; 2-Tr; 2-M; 1-To; 3-Pa 
C52 + 2,764 2,306 + 0,558 + 2,831 + 2,949 + n.d.l 3-R; 2-To 
C63 + 1,561 1,320 + 0,143 + 0,748 + 1,085 + + 2-R 
C69 + 0,145 0,095 + 0,037 - -0,007 - -0,008 + - 0 
C70 - 0,051 -0,168 - 0,180 + 0,135 + 0,189 - - 0 
C72 + 0,786 0,747 + 0,056 + 0,520 + 0,332 + + 3-R 
C80 + 1,308 1,160 + 0,197 + 0,954 + 0,843 + - 1-To 
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